Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 10-K

 


 

(Mark One)

 

x   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2002

 

OR

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from            to            

 

Commission File Number: 0-1649

 


 

NEWPORT CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Nevada

 

94-0849175

(State or other jurisdiction of
incorporation or organization)

 

(IRS Employer Identification No.)

 

1791 Deere Avenue, Irvine, California 92606

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code:  (949) 863-3144

 


 

Securities registered pursuant to Section 12(b) of the Act:  None

 

Securities registered pursuant to Section 12(g) of the Act:  Common Stock, Stated Value $0.1167 per share

 


 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.    ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).    Yes  x    No  ¨

 

As of February 28, 2003, 38,580,925 shares of the registrant’s sole class of common stock were outstanding. As of February 28, 2003, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $596 million, calculated based upon the closing price of our common stock as reported by the Nasdaq Stock Market on June 28, 2002.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the registrant’s Proxy Statement for its Annual Meeting of Stockholders to be held on May 21, 2003 are incorporated by reference into Part III of this Annual Report on Form 10-K.

 



Table of Contents

TABLE OF CONTENTS

 

    

PART I

    

Item 1.

  

Business

  

1

Item 2.

  

Properties

  

11

Item 3.

  

Legal Proceedings

  

11

Item 4.

  

Submission of Matters to a Vote of Security Holders

  

12

    

PART II

    

Item 5.

  

Market for the Registrant’s Common Equity and Related Stockholder Matters

  

13

Item 6.

  

Selected Financial Data

  

13

Item 7.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

15

Item 7A.

  

Quantitative and Qualitative Disclosures About Market Risk

  

32

Item 8.

  

Financial Statements and Supplementary Data

  

33

Item 9.

  

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

  

33

    

PART III

    

Item 10.

  

Directors and Executive Officers of the Registrant

  

34

Item 11.

  

Executive Compensation

  

34

Item 12.

  

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

  

34

Item 13.

  

Certain Relationships and Related Transactions

  

34

Item 14.

  

Controls and Procedures

  

34

    

PART IV

    

Item 15.

  

Exhibits, Financial Statement Schedules, and Reports on Form 8-K

  

35

SIGNATURES

  

38

CERTIFICATIONS

  

39

INDEX TO FINANCIAL STATEMENTS AND SCHEDULES

  

F-1

 

i


Table of Contents

This Annual Report on Form 10-K contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Annual Report on Form 10-K except for historical information may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue” or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ depending on a variety of important factors, including those described herein in the sections entitled “Business” and “Risks Relating To Our Business.”

 

PART I

 

Item 1.    Business

 

General Description of Business

 

Newport Corporation is a global supplier of advanced technology products and systems to a wide range of industries, including semiconductor manufacturing and advanced packaging equipment, aerospace and defense, life and health sciences, scientific research and fiber optic communications. We provide:

 

    components and integrated subsystems to manufacturers of semiconductor front-end processing equipment;

 

    automated systems for semiconductor back-end packaging applications to integrated device manufacturers;

 

    automated assembly and test systems to manufacturers of fiber optic components; and

 

    a broad array of high-precision components and instruments to commercial, academic and government customers worldwide.

 

Our products leverage our expertise in precision robotics and automation, high-precision positioning systems, vibration isolation technology, precision optics and optomechanics to enhance the capabilities and productivity of our customers’ manufacturing, engineering and research applications.

 

Within the semiconductor industry, the manufacturing of devices is often divided into two areas – front-end wafer processing and back-end packaging. Over the years, we have developed a significant presence as a supplier to top-tier equipment manufacturers for front-end applications, providing high-performance components and subsystems that enhance the performance of these customers’ products. More recently, we have become an integrated systems supplier for advanced back-end packaging applications. With well-designed and tested products, a flexible product portfolio and a strong intellectual property position, we now offer our customers advanced products for both front-end and back-end semiconductor manufacturing processes.

 

In addition to our presence in the semiconductor industry, we also supply components, instruments and subsystems to a broad range of other markets, including basic and applied scientific research, aerospace and defense and, increasingly, in life and health sciences. Our component and subsystem products are often incorporated into the high-precision products of customers in these industries. We also provide high-performance components and instruments to commercial, academic and governmental research institutions worldwide that engage in research and development activities.

 

We also continue to be a leading supplier of automated and manually operated equipment used to assemble and test fiber optic telecommunications and data communications devices. Our unique machines, which combine our proven technology with advanced computer software and our in-depth industry and process expertise, are

 

1


Table of Contents

used around the world to manufacture and test active and passive telecommunication components. These systems provide our customers with the flexibility required to facilitate the development of new components and manufacturing processes for next-generation telecommunications equipment.

 

For over three decades we have serviced the needs of research laboratories for precision equipment. Since 1991, we have acquired a series of companies to expand our product offerings, technology base and geographic presence. Through these acquisitions and our internal development efforts, we have evolved from a provider of discrete components and instruments for research applications to a company that manufactures both components and integrated systems for research and commercial applications. In particular, during 2001 we acquired Kensington Laboratories, Inc. (KLI), a manufacturer of high-precision robotic and motion control equipment primarily for the semiconductor equipment industry, and during 2002 we acquired Micro Robotics Systems, Inc. (MRSI), a manufacturer of high-precision, fully-automated assembly and dispensing systems for back-end packaging applications in the semiconductor, microwave communications and fiber optic communications markets. Both of these acquisitions significantly increased our product offerings and expertise in these areas. We pursue acquisitions of companies, technologies and complementary product lines that we believe will provide us with key technologies, give us access to new markets or otherwise further our strategic objectives. Conversely, from time to time we review our different businesses, including our acquired companies, to ensure that they are key to our strategic plans, and close or divest businesses that we determine are no longer of strategic importance. See Management’s Discussion and Analysis of Financial Condition and Results of Operations – Overview and Note 3 of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.

 

Products and Services

 

We develop and sell a broad range of components, instruments, subsystems and systems to markets where high-precision, efficient manufacturing, test and assembly are critical. Our products are used in mission-critical applications in industries including semiconductor manufacturing, aerospace and defense, life and health sciences and fiber optic device manufacturing. We develop, manufacture and market products within two distinct business segments, Advanced Packaging and Automation Systems and Industrial and Scientific Technologies. During 2002, following our divestiture of our Industrial Metrology Systems division, we reorganized our business segments to align them more closely with customer and manufacturing requirements. This structure enables us to quickly incorporate customer feedback into new products and to respond rapidly to changing market requirements.

 

Advanced Packaging and Automation Systems Division

 

Within the semiconductor industry, the manufacturing of devices is often divided into two areas – front-end wafer processing and back-end packaging. Our Advanced Packaging and Automation Systems division offers a broad array of automation subsystem products for semiconductor front-end wafer processing applications, and also supplies complete turnkey systems for advanced back-end packaging applications. The division also offers a complete line of assembly and test automation systems for the fiber optic communications industry, addressing a wide spectrum of applications in the fiber optic component manufacturing process, from pre-test to assembly and packaging to final device testing and burn-in. These high-performance products provide our customers with the speed, accuracy, repeatability and dependability they require for high-throughput production environments.

 

Semiconductor Front-End Technologies

 

Our Advanced Packaging and Automation Systems division offers a broad array of products for front-end semiconductor process applications, including automated wafer handling subsystems such as atmospheric robots, load ports and wafer alignment stations. We are a leader in advanced robotic systems technologies, and we are committed to developing and manufacturing the highest performance, most reliable and most cost-effective atmospheric wafer handling robots and load ports in the industry.

 

2


Table of Contents

 

    Atmospheric Wafer Handling Robots.    We sell a full range of atmospheric robots that automate the handling of semiconductor wafers in the ultra-clean environment of a processing or inspection tool. We hold a number of issued and pending patents on state-of-the-art edge-gripping robotic end effectors that are critical to enabling semiconductor equipment manufacturers to efficiently and reliably handle 300-millimeter wafers without contacting the backside of the wafer, an important technique in reducing contamination and the resultant yield losses. Our wafer handling robots also feature our patented automated teaching technology, which allows the robot to be programmed more accurately and more consistently, reducing setup time. All of our 300-millimeter wafer handling robots incorporate our patented optical sensing technology in the end effector to maximize the accuracy of the robot while simplifying the setup and calibration process.

 

    Load Ports.    Our automatic door opener system (ADO) is a load port for 300-millimeter wafers that serves as the physical interface between a processing or inspection tool and the operators or automated material handling system used to transport wafers throughout the fabrication environment. We hold a number of issued and pending patents on this technology, which allows wafers to be efficiently and reliably loaded into a manufacturing process or inspection tool while maintaining an ultra-clean environment. The ADO is easy to install, conforms to industry standards, and is compatible with popular wafer transport pods, known in the industry as FOUPs. Our patented latchkey opening mechanism produces reliable and consistent pod door openings, minimizing wafer handling errors, positional errors and contamination, leading to superior load port to FOUP interoperability. The ADO provides throughput performance that is among the highest in the industry under Class 1 clean room conditions.

 

    Wafer Alignment Stations.    In 2002, we introduced a new edge-gripping wafer prealigner, a patented design based on our innovative edge-grip wafer handling technology. This product enables our customers to rapidly and precisely align 300-millimeter wafers prior to insertion into the processing or inspection tool, without contacting the backside of the wafer. This reduces losses due to particle contamination of the wafer, helping to improve process yields.

 

Advanced Packaging Systems

 

In February 2002, we acquired MRSI, a leading supplier of automated assembly and dispensing systems to the semiconductor packaging, microwave and fiber optic communications industries. We offer a full line of automated chip assembly equipment, including die bonding and flip chip bonding systems, as well as epoxy-dispensing and flip chip underfill systems, that are used to manufacture microwave, optical, radio frequency (RF) and multi-chip modules.

 

    Automated Assembly Systems.    Our MRSI-505 family of products provide users with high-speed, high-precision solutions for the automated assembly of a variety of microelectronic and optoelectronic devices. The family of systems features three models, each optimized to address a different advanced packaging application. The MRSI-505 Advanced Packaging Work Cell is specifically designed and configured for advanced packaging applications required for medical, military, automotive and computer applications. The MRSI-505 High Frequency Work Cell is designed to meet the particular eutectic bonding requirements of applications such as radio frequency (RF), microwave and millimeter-wave modules. The MRSI-505 Photonics Work Cell is configured for the particular eutectic bonding requirements of photonics applications, such as building laser submounts and photodetectors. We also offer the MRSI-5005 Optical Assembly Work Cell, which is specially designed to produce extremely precise placements required for certain photonics applications.

 

   

Automated Dispensing Systems.    Our MRSI-175 family of products provides users with high-speed, high-performance solutions for a range of automated dispensing applications. The MRSI-175Ag Conductive Epoxy Dispensing System is designed to provide the process control and dispensing capability required for demanding applications such as microwave modules, optical modules, hybrid

 

3


Table of Contents
 

circuits, multichip modules, and semiconductor packaging. The MRSI-175UF Underfill Dispensing System is a high-speed, high-accuracy, automated dispenser designed for flip chip underfill applications.

 

Fiber Optic Communications

 

Our Advanced Packaging and Automation Systems division is a leading supplier of automated and manually operated equipment used to assemble and test fiber optic telecommunications and data communications devices. Our unique machines are used around the world to manufacture and test active and passive telecommunications components, and feature the flexibility required to facilitate the development of new components and manufacturing processes for next-generation telecommunications equipment. Our Advanced Process Technology group also offers a full range of process engineering services, from technology transfer and process development activities through complete package design/development and pilot lot manufacturing services, to enable our customers to develop and qualify their next generation photonic telecommunication and data communication devices.

 

Our product offering includes automated assembly, device characterization, fiber alignment and attachment and final device characterization and life testing systems. Of particular note are our automated assembly systems for the manufacture of various types of Vertical Cavity Surface Emitting Lasers (VCSELs) and VCSEL array devices. VCSELs are expected to be an important technology as metro-area fiber optic networks are implemented. Our fiber optic device manufacturing and test systems take advantage of many of our core technology strengths, including precision robotic parts handling, motion control, vibration isolation, optics, software integration and automation.

 

    Pre-Test.    Our pre-test products automate the testing of devices used in fiber optic components, such as laser diodes, to ensure their integrity prior to the start of the assembly process. We offer a range of products, from manually operated to fully automated, that increase the efficiency of the pre-test and inspection process, including laser diode characterization systems.

 

    Assembly and Packaging.    The assembly and packaging of fiber optic components require the positioning and attachment of very small subcomponents with a high degree of precision. Manufacturers have traditionally used manual assembly techniques for fiber optic components. These techniques result in low production yields and produce inconsistent quality. We offer a full range of integrated assembly and packaging systems, including automated, semi-automated and manually operated systems, which can simplify or automate these processes and help reduce manufacturing times, increase yields and enhance quality. Our automated and semi-automated systems utilize common architectures and process control software, enabling the user to upgrade their system to increase their level of automation as their needs change. Our assembly and packaging products include fiber alignment and attachment systems using welding, soldering and epoxy attachment techniques.

 

    Final Device Testing and Burn-In.    Fiber optic devices must meet rigorous reliability and performance specifications, including requirements such as 20 to 30 year life cycles and the ability to perform in harsh weather conditions or even underwater. These performance standards require manufacturers to perform extensive testing of the devices both prior to and following assembly. We offer standardized systems which automate the burn-in and life testing process for either the partially assembled or fully packaged laser diodes.

 

Engineering and Manufacturing Services

 

Due to our extensive experience in fiber optic device assembly, packaging and testing technology, we have a deep knowledge base and expertise in the processes and technologies necessary to build high-precision fiber optic components. In addition, our acquisitions in recent years have expanded our knowledge base and expertise in the use of flexible automation solutions for the manufacture of fiber optic components, as well as in the integration of production lines for chip packaging and module assembly. We apply this expertise to assist our customers in designing device packaging, developing manufacturing processes, developing and producing

 

4


Table of Contents

tooling and programming customized process automation software. These services help customers significantly reduce the development cycle for their products and improve the productivity, yields and quality of their manufacturing processes. In addition to helping customers become more productive, these services assist us in establishing a long-term relationship with our customers and allow us to identify additional opportunities for new products. We also offer device manufacturing and packaging services to enable customers to design and test new products. We believe that the extent of our capabilities and services in this area provides us with a key competitive advantage over other capital equipment suppliers to this market.

 

Industrial and Scientific Technologies Division

 

Our Industrial and Scientific Technologies division’s products are used across a wide range of industrial markets in applications that range from basic research and development activities to high-precision manufacturing. In addition, we sell subsystems to third parties that integrate these products into larger systems, particularly for semiconductor manufacturing. Our industrial and scientific products address a wide range of markets, including semiconductor equipment, life and health sciences, aerospace and defense, scientific research and fiber optic communications. These products and technologies also form the foundation of certain of the integrated, automated systems sold by our Advanced Packaging and Automation Systems division. We believe that purchasers of our Industrial and Scientific Technologies division’s products develop an appreciation for the quality of our products which makes them more likely to buy integrated, automated systems from us as the need for production and test systems grows. Our Industrial and Scientific Technologies division’s product lines include:

 

Category

 

Products

 

Applications


Precision Micro-Positioning Devices, Systems and Subsystems










 

•       Precision air bearing stages

 

•       Motion systems

 

•       Linear and rotational stages

 

•       Elevational devices

 

•       Actuators

 

•       Simple and programmable motion controllers for linear stepping and direct current (DC) motors








 

•       Precision positioning of semiconductor wafers for metrology and fabrication

 

•       Sample sorting and sequencing for DNA research

 

•       High-precision positioning and motion control apparatus for manufacturing and test applications

 

•       Tracking and targeting test systems for aerospace and defense applications

 

•       Precision alignment in fiber optic, telecommunication and laser device assembly

 

5


Table of Contents

Category

 

Products

 

Applications


Vibration Isolation Systems and Subsystems








 

•       Optical benches and support systems

 

•       Workstations

 

•       Active and passive isolation systems

 

•       Honeycomb, granite and rigid structures

 

•       Elastomeric mounts








 

•       Isolated floor for semiconductor lithography equipment

 

•       Foundation platforms for laser systems

 

•       Reduction of impact of external forces on high-precision research, manufacturing test and assembly systems

 

•       Scanning electron microscope/atomic force microscope base isolation

 

•       Workstation platforms for optical fiber fabrication


Optics
















 

•       Fast steering mirrors

 

•       Lenses

 

•       Mirrors

 

•       Prisms and windows

 

•       Filters and attenuators

 

•       Collimators

 

•       Ultrafast laser optics

 

•       Beamsplitters and polarization optics

 

•       Optical systems








 

•       Thin film measurement of semiconductor wafers for defect inspection

 

•       Deep ultraviolet illumination optics for semiconductor lithography

 

•       Laser beam stabilization for industrial metrology applications

 

•       Components for research and product development activities

 

•       Blood cell analysis


Manual Positioning Components












 

•       Optical mounts

 

•       Bases and brackets

 

•       Posts and rod systems

 

•       Translation and rotation stages

 

•       Laser-to-fiber couplers

 

•       Manual fiber optic positioners

 

•       Educational kits










 

•       Laser systems

 

•       Subsystems used for high-speed cell sorting for genomic research

 

•       Analytical instrumentation for life and health sciences

 

•       Manual, high-precision alignment of optical instruments

 

•       Electro-optical research

 

•       Manual assembly of fiber optic devices

 

6


Table of Contents

Category

 

Products

 

Applications


Photonics Instruments






 

•       Power meters

 

•       Laser diode instruments

 

•       Optical spectrum analyzers

 

•       Photonics test systems






 

•       Measure optical power for free space and fiber-directed laser light

 

•       Temperature and current controllers for maintaining stability of laser diodes

 

•       Characterization of light emitted by laser diodes, ion lasers and solid state lasers

 

•       Testing and qualification of optical fibers and passive fiber optic components

 

We also offer subassemblies that are a value-added combination of standard and custom products drawn from the components, optics, robotics, motion control and vibration isolation product lines. We combine these items with additional engineering to create more highly integrated products to meet customer needs. These products are often subsystems of our original equipment manufacturer (OEM) customers’ products. We believe that this subassembly capability gives us a significant competitive advantage by differentiating us from competitors that offer a more limited product selection.

 

Financial information regarding our two business segments, and our operations by geographic area, is included in Note 15 of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K beginning on page F-24. A discussion of our net sales by end market and geographic area is included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

Sales and Marketing

 

We market and sell our products and services through our domestic and international sales organizations, an international network of independent distributors and sales representatives, technical catalogs and our web site. Our domestic and international sales organizations are comprised of teams of field sales persons, which work closely with strategic account managers and internal sales support personnel based in our Irvine, California headquarters. Our customers often have unique technical specifications and manufacturing processes, and may require specific system, subsystem or component designs. This requires close cooperation between the sales personnel and distributors and the engineering staff, and can result in long sales cycles for our subsystem and capital equipment products. As of December 31, 2002, we employed 72 persons in our domestic sales organization, and 35 persons in our international sales organization, located in Canada, France, Germany, Italy, the Netherlands, Singapore, Sweden, Switzerland, Taiwan, and the United Kingdom.

 

We currently engage 22 independent sales representatives and distributors that actively market and sell our products in certain markets outside of North America. We have written agreements with each of our representatives and distributors. In some cases we have granted representatives and distributors exclusive authorization to sell certain of our products in a specific geographic area. These agreements generally have terms of one year and are renewable on an annual basis, and are generally terminable by either party for convenience following a specified notice period. Most distributor agreements are structured to provide distributors with sales discounts below the domestic list price. Representatives are generally paid commissions for sales of products. No single independent representative or distributor accounted for more than 5% of our net sales in 2002.

 

7


Table of Contents

 

We also market our standard products through our product catalog and web site. Our principal marketing tool for the scientific market is our comprehensive product catalog, The Newport Resource. This catalog, numbering approximately 1,400 pages, provides detailed product information as well as extensive technical and applications data. We publish this catalog in English, French, German and Japanese, and mail it to approximately 40,000 existing and potential customers. New product supplements are also distributed between publications. Our web site features an online catalog, providing customers with access to the latest information regarding our products, technical/tutorial and application related materials, sales information, a literature and information request form, and the ability to purchase a majority of our standard products.

 

Research and Product Development

 

We continually seek to improve our technological leadership position through internal research, product development and licensing, and acquisitions of complementary technologies. As of December 31, 2002, we had 148 employees engaged in research and development in our continuing operations. We continually work to enhance our existing products and to develop and introduce innovative new products to satisfy the needs of our customers. In addition, we regularly investigate new ways to combine components manufactured by our various divisions to produce innovative technological solutions for the markets we serve. Research and development expenses were $24.4 million, or 14.9% of net sales, in 2002, $26.1 million, or 9.0% of net sales, in 2001, and $21.7 million, or 8.3% of net sales, in 2000. We are committed to product development and expect to continue our investment in this area in the current and future years.

 

We believe that the continual development or acquisition of innovative new products will be critical to our future success. Failure to develop, or introduce on a timely basis, new products or product enhancements that achieve market acceptance could have a material adverse effect on our business, operating results or financial condition.

 

Customers

 

We sell our products to a significant number of customers worldwide, in a wide range of diverse end markets, including semiconductor manufacturing and advanced packaging equipment, aerospace and defense, life and health sciences, scientific research and fiber optic communications. We believe that our diversification in this area minimizes our dependence on any single industry or group of customers. Sales during 2002 to one customer of our Advanced Packaging and Automation Systems division, Applied Materials, Inc., totaled $17.8 million, which represented 38.4% of our 2002 net sales to that segment and 10.9% of our consolidated net sales for the year. In addition, 2002 sales to one customer of our Industrial and Scientific Technologies division represented 13.1% of our 2002 net sales to that segment, but less than 10% of our consolidated net sales for the year. We believe that our relationships with these customers are good. However, if Applied Materials, Inc. or any other key customer discontinues or reduces its relationship with us, or suffers downturns in its business, it could have a significant negative impact on our financial results on a short-term basis, and our business and results of operations could be harmed going forward if we are unable to sufficiently expand our customer base to replace the lost business.

 

Competition

 

The markets for our products are intensely competitive and characterized by rapidly changing technology. In the semiconductor market, for front-end processing applications, our primary competitors are currently Asyst Technologies, Inc., Brooks-PRI Automation, Inc., Genmark Automation, Inc., Kawasaki Heavy Industries, Ltd., and Yaskawa Electric Corp. for our wafer handling robots; and Asyst Technologies, Inc., Brooks-PRI Automation, Inc. and TDK Corporation for our load ports. For semiconductor back-end packaging applications, our primary competitors are Datacon Technology AG, ESEC, F&K Delvotech, and Palomar Technologies, for our automated assembly systems, and Asymtek, Cookson Electronics, Inc., and Protec Co., Ltd. for our dispensing systems.

 

8


Table of Contents

 

In the fiber optic communications market, our primary competitors are currently AOI Sansho, EXFO Electro-Optical, Inc., Palomar Technologies and Suruga-Seiki Co., Ltd., for our assembly automation systems; and Agilent Technologies, Inc., Ando Corporation, Anritsu Corporation, EXFO Electro-Optical Inc., Moritex Corporation, and Racal, Inc. for our test and measurement systems.

 

In our industrial and scientific technologies business, our primary competitors are currently Aerotech Inc., Danaher Corporation, and Dover Corp. for our precision motion systems; Kinetic Systems, Inc., Melles Griot, Inc., and Technical Manufacturing Corp. for our vibration isolation products; and CVI Laser Corporation, Corning Tropel Corporation, Melles Griot, Inc., New Focus, Inc. and Thorlabs, Inc. for our precision optics and optomechanical products.

 

In each of our businesses, we also face competition from certain of our existing and potential customers who have developed or may develop their own systems, subsystems and components.

 

We believe that the primary competitive factors in our markets are:

 

    product features and performance;

 

    quality, reliability and service support;

 

    customer relationships;

 

    ability to manufacture and deliver products on a timely basis;

 

    pricing; and

 

    ability to customize products to customer specifications.

 

We believe that we currently compete effectively with respect to each of these factors. However, we may not be able to compete successfully in the future against existing or new competitors.

 

We compete in various markets against a number of companies, some of which have longer operating histories, greater name recognition and significantly greater technical, financial, manufacturing and marketing resources than we do. In addition, some of these companies have long established relationships with our customers and potential customers in our markets. In addition to current competitors, we believe that new competitors, some of whom may have substantially greater financial, technical and marketing resources than us, will seek to provide products to one or more of our markets in the future. Such future competition could harm our business.

 

Intellectual Property and Proprietary Rights

 

Our success and competitiveness depends to an extent on our technology and other intellectual property such as trade secrets, patents and trademarks. We protect our technology by controlling access to our proprietary information and by maintaining confidentiality agreements with our employees and consultants and our customers and partners, and, in some cases, through the use of patents, trademark registrations, and licenses. We have been granted a number of patents in the U.S. and foreign jurisdictions. We also have trademarks registered in the U.S. and foreign jurisdictions. We actively pursue applications for new patents and trademarks as we deem appropriate.

 

It is possible that, despite our efforts, other parties may use, obtain or try to copy our products and technology. Policing unauthorized use of our products and technology is difficult and time consuming. We cannot guarantee that the steps we take to protect our rights will prevent any misappropriation of our products or technology. This is particularly the case in foreign jurisdictions, where the intellectual property laws may not afford our intellectual property rights the same protection as the laws of the United States. In addition, infringement, invalidity, right to use or ownership claims by third parties may be asserted against us in the future, which claims could materially harm our business, operating results or financial condition, regardless of the outcome.

 

9


Table of Contents

 

Manufacturing

 

We assemble, test and package components and systems at domestic manufacturing facilities located in Chandler, Arizona; Irvine, California; Richmond, California; and North Billerica, Massachusetts, and at our international manufacturing facilities in Beaune-la Rolande, France and La Boulonnie, France. In addition, we subcontract the manufacture of various products and components to a number of third-party subcontract manufacturers.

 

Our manufacturing processes are diverse and consist of: purchasing raw materials, principally stainless steel, aluminum and glass; processing the raw materials into components, subassemblies and finished products; purchasing components, assembling and testing components and subassemblies; and, for our larger products, assembling the subassemblies and components into integrated systems. We primarily design and manufacture components internally, although on a limited basis, we purchase completed products from certain third-party suppliers and resell those products through our distribution system. Most of these completed products are produced to our specifications and carry our name and logo.

 

We currently procure various components from single-sources due to unique component designs as well as certain quality and performance requirements. In addition, we manufacture certain components internally, and there are no readily available third-party suppliers of these components. If single-sourced components were to become unavailable or were to become unavailable on terms satisfactory to us, we would be required to purchase comparable components from other sources. While we believe that we would be able to obtain comparable replacement components from other sources in a timely manner, if we are unable to do so our business, results of operations or financial condition could be adversely affected.

 

We have not incurred significant expenses related to environmental compliance in past periods, and, due to the nature of our businesses, do not expect to incur such expenses in the future.

 

Backlog

 

Our consolidated backlog of products totaled $33.9 million and $50.3 million at December 31, 2002 and 2001, respectively. Orders for many of the products we sell to the semiconductor equipment and fiber optic communications markets, which comprise a significant portion of our sales, are often subject to cancellation or rescheduling by the customer, and we have from time to time experienced significant cancellations and pushouts of orders from these markets, which negatively affected our operating results in those periods. In addition, because we manufacture a significant portion of our standard catalog products for inventory, we often make shipments of these products upon or within a short time period following receipt of an order. As a result, our backlog of orders at any particular date may not be an accurate indicator of our sales for succeeding periods.

 

Investments

 

In addition to the ownership of subsidiaries detailed in Exhibit 21.1 to this Annual Report on Form 10-K, we from time to time make investments in companies involved in developing products and technologies related to our business, and we currently hold minority ownership interests in a number of small, privately-held companies. These investments are designed to further our strategic objectives and to support our key business initiatives. We want to support growth in new technologies, particularly those related to our strategic markets, in order to create and expand markets for our products. While financial returns are not our primary goal, our strategic investment program seeks to invest in companies that can succeed and have a positive impact on their markets. At December 31, 2002, the carrying value of our investments totaled $2.1 million. Investments in technology companies involve significant risks, including the risks that such companies may be unable to raise additional required operating capital on acceptable terms or at all, or may not achieve or maintain market acceptance of their technology or products. In the event that any of such risks occurs, the value of our investment could decline significantly. In addition, because there is no public market for the securities we acquire, our ability to liquidate

 

10


Table of Contents

our investments is limited, and such markets may not develop in the future. In 2002, two fiber optic component manufacturers in which we had made minority investments in prior years experienced severe financial difficulties. One manufacturer shut down its business and liquidated its assets, and the other manufacturer filed for bankruptcy protection. As a result, we recorded an asset write-down of $6.5 million relating to these investments. In the event that we are required to write-down the carrying value of one or more of our investments in the future, our earnings could be materially and adversely affected.

 

Employees

 

As of February 28, 2003, we had 1,088 employees worldwide engaged in our continuing operations. None of our employees are represented by a union. We believe that our relationships with our employees are good.

 

Availability of Reports

 

We make available free of charge on our web site at www.newport.com our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any amendments to such reports, as soon as reasonably practicable after such reports are filed with the Securities and Exchange Commission. We will also provide electronic or paper copies of such reports free of charge, upon request made to our Corporate Secretary.

 

Item 2.    Properties

 

Our corporate headquarters is located in Irvine, California. We lease this facility under a lease expiring in February 2012. Our primary manufacturing operations for each of our divisions are located in the following facilities:

 

Division


 

Primary Facilities


Advanced Packaging and Automation Systems

 

Chandler, Arizona

Irvine, California

Richmond, California

North Billerica, Massachusetts

Industrial and Scientific Technologies

 

Irvine, California

Beaune-la Rolande, France

La Boulonnie, France

 

We own our La Boulonnie, France facility and a portion of our Beaune-la Rolande, France facility. We lease all other facilities under leases with expiration dates ranging from 2003 to 2030. In addition to these primary facilities, we lease 12 facilities worldwide for administration, research and development, sales and/or service. We believe that our facilities are adequate for our current needs and that suitable additional or substitute space will be available in the future on commercially reasonable terms to accommodate expansion of our operations.

 

Item 3.    Legal Proceedings

 

In August 1999, Newport Electronics, Inc., a manufacturer of electronic devices, filed suit against us in Federal District Court in Connecticut, claiming that our use of the “Newport” trademark infringes its rights with respect to such mark. In January 2002, a trial was held with respect to this litigation, and the jury returned a verdict in our favor on all of Newport Electronics’ claims. In February 2002, Newport Electronics filed a motion for a new trial, which was denied by the District Court. Newport Electronics appealed such judgment to the Second Circuit Court of Appeals, which affirmed the judgment of the District Court on February 24, 2003.

 

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. We currently are not a party to any legal proceedings, the adverse outcome of which,

 

11


Table of Contents

in management’s opinion, individually or in the aggregate, would have a material adverse effect on our results of operations or financial position or cash flows.

 

Item 4.    Submission of Matters to a Vote of Security Holders

 

No matters were submitted to a vote of security holders during the fourth quarter of the year ended December 31, 2002.

 

12


Table of Contents

 

PART II

 

Item 5.    Market for the Registrant’s Common Equity and Related Stockholder Matters

 

Price Range of Common Stock

 

Our common stock is traded on the Nasdaq National Market under the symbol NEWP. As of February 28, 2003, we had 1,260 common stockholders of record based upon the records of our transfer agent which do not include beneficial owners of common stock whose shares are held in the names of various securities brokers, dealers and registered clearing agencies. The quarterly high and low sales prices of our common stock for the fiscal years ended December 31, 2002 and 2001 are included in Note 17, Supplementary Quarterly Consolidated Financial Data (Unaudited), of the Notes to Consolidated Financial Statements on page F-27.

 

Dividends

 

We declared no dividends on our common stock during 2002. On May 30, 2001, we declared a semi-annual cash dividend of $0.01 per share of our common stock, which was paid on July 10, 2001 to all stockholders of record at the close of business on June 15, 2001. In September 2001, we announced the cancellation of our semi-annual $0.01 per share dividend, because we believe that the funds required for the dividend could be deployed more effectively in our business. We do not intend to pay cash dividends in the foreseeable future, however, we will periodically review this issue in the future based on changes in our financial position and investment opportunities, as well as any changes in the tax treatment of dividends.

 

Item 6.    Selected Financial Data

 

The table below presents selected consolidated financial data of Newport and our subsidiaries as of and for the years ended December 31, 2002, 2001, 2000, 1999, and 1998. Financial data presented incorporates the results of operations and financial position of Unique Equipment Co. (Unique) and KLI; both entities merged with Newport in 2000 and 2001, respectively, and were accounted for as poolings of interests for all periods presented. This data has been derived from our audited consolidated financial statements and should be read in conjunction with the full consolidated financial statements and associated notes and with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for such periods.

 

FOR THE YEAR:

  

2002


    

2001


    

2000


    

1999


    

1998


 

(In thousands, except percent, per share and worldwide employment)

      

Net sales

  

$

163,994

 

  

$

289,963

 

  

$

262,597

 

  

$

143,146

 

  

$

143,347

 

Cost of sales(1)

  

 

138,183

 

  

 

192,698

 

  

 

138,539

 

  

 

76,543

 

  

 

74,430

 

    


  


  


  


  


Gross profit

  

 

25,811

 

  

 

97,265

 

  

 

124,058

 

  

 

66,603

 

  

 

68,917

 

Selling, general and administrative expense

  

 

50,222

 

  

 

57,311

 

  

 

51,453

 

  

 

33,319

 

  

 

30,095

 

Research and development expense

  

 

24,383

 

  

 

26,073

 

  

 

21,682

 

  

 

14,654

 

  

 

11,782

 

Restructuring and impairment charges

  

 

11,883

 

  

 

11,584

 

  

 

—  

 

  

 

—  

 

  

 

—  

 

Acquisition and other non-recurring charges

  

 

—  

 

  

 

10,683

 

  

 

—  

 

  

 

—  

 

  

 

—  

 

    


  


  


  


  


Operating income (loss)

  

 

(60,677

)

  

 

(8,386

)

  

 

50,923

 

  

 

18,630

 

  

 

27,040

 

Interest and other income (expense), net

  

 

10,269

 

  

 

13,786

 

  

 

6,041

 

  

 

(1,833

)

  

 

(1,686

)

Asset write-down

  

 

(6,490

)

  

 

—  

 

  

 

—  

 

  

 

—  

 

  

 

—  

 

    


  


  


  


  


Income (loss) from continuing operations before income taxes

  

 

(56,898

)

  

 

5,400

 

  

 

56,964

 

  

 

16,797

 

  

 

25,354

 

Income tax provision

  

 

14,011

 

  

 

1,929

 

  

 

12,936

 

  

 

3,850

 

  

 

4,136

 

    


  


  


  


  


Income (loss) from continuing operations

  

 

(70,909

)

  

 

3,471

 

  

 

44,028

 

  

 

12,947

 

  

 

21,218

 

Loss from discontinued operations, net of income taxes

  

 

(15,209

)

  

 

(9,743

)

  

 

(2,055

)

  

 

(1,926

)

  

 

(1,640

)

Cumulative effect of a change in accounting principle

  

 

(14,500

)

  

 

—  

 

  

 

—  

 

  

 

—  

 

  

 

—  

 

    


  


  


  


  


Net income (loss)

  

$

(100,618

)

  

$

(6,272

)

  

$

41,973

 

  

$

11,021

 

  

$

19,578

 

    


  


  


  


  


 

13


Table of Contents

FOR THE YEAR:

  

2002


    

2001


    

2000


    

1999


    

1998


 

(In thousands, except percent, per share and worldwide employment)

      

Percent of net sales:

                                            

Gross profit

  

 

15.7

%

  

 

33.5

%

  

 

47.2

%

  

 

46.5

%

  

 

48.1

%

Selling, general and administrative expense

  

 

30.6

 

  

 

19.8

 

  

 

19.6

 

  

 

23.3

 

  

 

21.0

 

Research and development expense

  

 

14.9

 

  

 

9.0

 

  

 

8.3

 

  

 

10.2

 

  

 

8.2

 

Restructuring and impairment charges

  

 

7.2

 

  

 

4.0

 

  

 

—  

 

  

 

—  

 

  

 

—  

 

Acquisition and other non-recurring charges

  

 

—  

 

  

 

3.7

 

  

 

—  

 

  

 

—  

 

  

 

—  

 

Operating income (loss)

  

 

(37.0

)

  

 

(2.9

)

  

 

19.4

 

  

 

13.0

 

  

 

18.9

 

Income (loss) from continuing operations

  

 

(43.3

)

  

 

1.2

 

  

 

16.8

 

  

 

9.0

 

  

 

14.8

 

Net income (loss)

  

 

(61.4

)

  

 

(2.2

)

  

 

16.0

 

  

 

7.7

 

  

 

13.7

 

PER SHARE:(2)

                                            

Earnings (loss) per share, basic:

                                            

Income (loss) from continuing operations

  

$

(1.87

)

  

$

0.10

 

  

$

1.32

 

  

$

0.42

 

  

$

0.69

 

Loss from discontinued operations, net of income taxes

  

$

(0.40

)

  

$

(0.27

)

  

$

(0.07

)

  

$

(0.06

)

  

$

(0.05

)

Cumulative effect of a change in accounting principle

  

$

(0.38

)

  

 

—  

 

  

 

—  

 

  

 

—  

 

  

 

—  

 

    


  


  


  


  


Net income (loss)

  

$

(2.65

)

  

$

(0.17

)

  

$

1.25

 

  

$

0.36

 

  

$

0.64

 

    


  


  


  


  


Earnings (loss) per share, diluted:

                                            

Income (loss) from continuing operations

  

$

(1.87

)

  

$

0.09

 

  

$

1.23

 

  

$

0.40

 

  

$

0.67

 

Loss from discontinued operations, net of income taxes

  

$

(0.40

)

  

$

(0.26

)

  

$

(0.06

)

  

$

(0.06

)

  

$

(0.05

)

Cumulative effect of a change in accounting principle

  

$

(0.38

)

  

 

—  

 

  

 

—  

 

  

 

—  

 

  

 

—  

 

    


  


  


  


  


Net income (loss)

  

$

(2.65

)

  

$

(0.17

)

  

$

1.17

 

  

$

0.34

 

  

$

0.62

 

    


  


  


  


  


Number of shares used to calculate earnings (loss) per share:

                                            

Basic

  

 

37,970

 

  

 

36,405

 

  

 

33,464

 

  

 

30,939

 

  

 

30,590

 

Diluted

  

 

37,970

 

  

 

37,830

 

  

 

35,835

 

  

 

32,075

 

  

 

31,842

 

Dividends paid

  

 

—  

 

  

$

0.01

 

  

$

0.02

 

  

$

0.01

 

  

$

0.01

 

Total stockholders’ equity per diluted share

  

$

11.76

 

  

$

13.33

 

  

$

13.43

 

  

$

2.65

 

  

$

2.70

 

AT YEAR END:

                                            

Cash and marketable securities

  

$

284,313

 

  

$

281,601

 

  

$

306,642

 

  

$

9,241

 

  

$

14,503

 

Working capital

  

 

331,329

 

  

 

389,318

 

  

 

426,294

 

  

 

51,762

 

  

 

59,169

 

Total assets

  

 

486,338

 

  

 

543,877

 

  

 

557,020

 

  

 

140,292

 

  

 

129,768

 

Total debt

  

 

3,444

 

  

 

9,598

 

  

 

17,130

 

  

 

26,070

 

  

 

23,635

 

Stockholders’ equity

  

 

446,517

 

  

 

489,007

 

  

 

485,965

 

  

 

83,246

 

  

 

85,893

 

MISCELLANEOUS STATISTICS:

                                            

Common shares outstanding(2)

  

 

38,560

 

  

 

36,693

 

  

 

36,196

 

  

 

31,413

 

  

 

31,049

 

Annual average worldwide employment

  

 

1,276

 

  

 

1,515

 

  

 

1,170

 

  

 

868

 

  

 

842

 

Sales per employee

  

$

129

 

  

$

191

 

  

$

224

 

  

$

165

 

  

$

170

 


(1)   For 2002 and 2001, includes inventory reserves of $28.7 million and $22.7 million, respectively, discussed in Note 2 of the Notes to Consolidated Financial Statements.
(2)   Share and per share amounts have been adjusted to reflect the May 2000 three-for-one stock split.

 

14


Table of Contents

Item 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This Item contains forward-looking statements that involve risks and uncertainties and actual results could differ materially from those anticipated in such statements as a result of various factors including those described below in “Risks Relating To Our Business.”

 

OVERVIEW

 

The following is a discussion and analysis of certain factors that have affected our results of operations and financial condition during the periods included in the accompanying financial statements. This discussion should be read in conjunction with the consolidated financial statements and associated notes.

 

Acquisitions

 

In February 2002, we acquired Micro Robotics Systems, Inc. (MRSI), a manufacturer of high-precision, fully-automated assembly and dispensing systems, for 2,084,825 shares of our common stock (including 1,087,541 shares issuable upon the exercise of assumed stock options) and $15.0 million in cash. Assets acquired in connection with this transaction included cash of approximately $10.4 million. The transaction was accounted for using the purchase method. The acquisition expands our product offerings and technological capability for back-end packaging applications in the semiconductor, microwave communications, and fiber optic communications markets.

 

In August 2000, we acquired Unique Equipment Co. (Unique), a systems integrator specializing in robotics and automation. In February 2001, we acquired Kensington Laboratories, Inc. (KLI), a manufacturer of high-precision robotic and motion control equipment primarily for the semiconductor industry. We issued approximately 3,526,000 shares of common stock to the KLI shareholders in the transaction. Also in February 2001, we acquired Design Technology Corporation (DTC), a systems integrator specializing in the use of robotics and flexible automation solutions for manufacturing processes. The DTC acquisition was accounted for using the purchase method. The Unique and KLI acquisitions were accounted for using the pooling of interests method.

 

This discussion includes the effects of the acquisitions of Unique and KLI for all years presented and the effects of the acquisitions of MRSI and DTC from their dates of acquisition.

 

Divestitures

 

During March 2002, to more efficiently deploy our resources to those areas that are critical to product development efforts for our strategic markets, our Board of Directors approved management’s plan to sell our Industrial Metrology Systems division (IMSD), including the business of CEJohansson AB, a Sweden-based global supplier of advanced metrology systems that we acquired in December 2000. The IMSD division consists of three businesses: the contact measurement business, the non-contact metrology business and the measurement and calibration business. The contact measurement and non-contact metrology businesses were sold in 2002 for cash of approximately $10 million.

 

During August 2002, to increase the efficiency of our product development and manufacturing efforts, our Board of Directors approved management’s plan to sell our facility in Plymouth, Minnesota, which manufactures high-precision motion stages for the semiconductor equipment, computer peripheral, fiber optic communications and life and health sciences markets and is part of our Industrial and Scientific Technologies division. In the first quarter of 2003, due to the weak response from potential buyers, we decided to shut down the facility and liquidate the majority of the remaining assets. We expect to complete the shutdown by April 2003.

 

15


Table of Contents

 

Both of these divestitures have been accounted for as discontinued operations pursuant to Financial Accounting Standards Board (FASB) Statement No. 144, Accounting for the Impairment or Disposal of Long Lived Assets and, accordingly, all prior periods presented have been adjusted to reflect the financial results of these operations as discontinued operations.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations is based on our consolidated financial statements included in this Annual Report on Form 10-K, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. On an ongoing basis, we evaluate these estimates and assumptions, including those related to allowance for doubtful accounts, inventory reserves, warranty obligations, restructuring reserves, asset impairment valuations and income tax valuations. We base these estimates on historical experience and on various other factors which we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. These estimates and assumptions by their nature involve risks and uncertainties, and may prove to be inaccurate. In the event that any of our estimates or assumptions are inaccurate in any material respect, it could have a material adverse effect on our reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

 

The following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.

 

Revenue Recognition.    We record a sale after all significant obligations have been met, collectibility is probable and title has passed, which typically occurs upon shipment or completion of services. Customers generally have 30 days from the original invoice date (generally 60 days for international customers) to return a standard catalog product purchase for exchange or credit. The catalog product must be returned in its original condition and meet certain other criteria. Product returns of catalog items have historically been insignificant and are charged against revenue in the period returned. Custom, option-configured and certain other products as defined in our terms and conditions of sale cannot be returned.

 

Accounts Receivable.    We estimate the collectibility of customer receivables on an ongoing basis by periodically reviewing invoices outstanding over a certain period of time. We have recorded reserves for receivables deemed to be at risk for collection, as well as a general reserve based on our historical collections experience. A considerable amount of judgment is required in assessing the ultimate realization of these receivables, including the current credit-worthiness of each customer. In recent periods we have increased our reserves for uncollectible accounts due to adverse changes in the financial condition of certain of our customers in the fiber optic communications market. If the financial conditions of our customers in this market continue to deteriorate, or if the financial conditions of our customers in the semiconductor and other markets we serve begin to deteriorate, resulting in an impairment of their ability to make required payments, additional allowances may be required which could adversely affect our operating results.

 

Inventory.    We state our inventories at the lower of cost, determined on either a first-in, first-out (FIFO) or average cost basis, or market and provide reserves for potentially excess and obsolete inventory. In assessing the ultimate realization of inventories, we make judgments as to future demand requirements and compare that with the current or committed inventory levels. Reserves are established for inventory levels that exceed expected future demand. We have recorded significant reserves, primarily for excess inventory, in recent periods due to deterioration in our primary target markets, fiber optic communications and semiconductor capital equipment. It is possible that additional changes in required inventory reserves may occur in the future due to changes in market conditions.

 

16


Table of Contents

 

Warranty.    Unless otherwise stated in our product literature, we provide a one-year warranty from the original invoice date on all product material and workmanship. Products sold to certain original equipment manufacturer customers sometimes carry longer warranties. Defective products will be either repaired or replaced, generally at our option, upon meeting certain criteria. We accrue a provision for the estimated costs that may be incurred for product warranties relating to a product as a component of cost of sales at the time revenue for that product is recognized. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers, our warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure. Should actual product failure rates, material usage and service delivery costs differ from our estimates, revisions to the estimated warranty obligation would be required which could adversely affect our operating results.

 

Impairment of Assets and Restructuring Reserves.    We assess the impairment of long-lived assets, other than goodwill, whenever events or changes in circumstances indicate that their carrying value may not be recoverable. The determination of related estimated useful lives and whether or not these assets are impaired involves significant judgments, related primarily to the future profitability and/or future value of the assets. Changes in our strategic plan and/or market conditions could significantly impact these judgments and could require adjustments to recorded asset balances. We hold minority interests in companies having operations or technologies in areas within or adjacent to our strategic focus, all of which are privately held and whose values are difficult to determine. We record an investment impairment charge in any reporting period where we believe an investment has experienced a decline in value that is other than temporary. In 2002, two fiber optic component manufacturers in which we had made minority investments in prior years experienced severe financial difficulties. One manufacturer shut down its business and liquidated its assets, and the other manufacturer filed for bankruptcy protection. As a result, we recorded an asset write-down of $6.5 million in 2002 relating to these investments. Future adverse changes in market conditions or poor operating results of underlying investments could result in losses or an inability to recover the carrying value of the investments that may not be reflected in an investment’s current carrying value, thereby possibly requiring an impairment charge in the future.

 

In 2001, the FASB issued Statement No. 141, Business Combinations (Statement 141), and No. 142, Goodwill and Other Intangible Assets (Statement 142), which we adopted on January 1, 2002. Under Statement 142, goodwill is no longer amortized but is subject to impairment tests based upon a comparison of the fair value of each of our reporting units, as defined, and the carrying value of the reporting units’ net assets, including goodwill. Pursuant to Statement 142, upon adoption we tested our goodwill for impairment and recorded an impairment charge, based upon an independent valuation, of $14.5 million as the cumulative effect of a change in accounting principle as of January 1, 2002. Statement 142 requires a review for impairment at least annually or when circumstances exist that would indicate an impairment of such goodwill. We perform the annual impairment review as of October 1 each year. The October 2002 annual review resulted in no additional impairment of the carrying value of goodwill. At December 31, 2002, we had goodwill of approximately $57.5 million. Had we not amortized goodwill, our net loss from continuing operations for the year ended December 31, 2001 would have decreased $2.5 million and our net income from continuing operations for the year ended December 31, 2000 would have increased $1.1 million.

 

During 2002 and 2001, we recorded significant reserves in connection with our restructuring and cost reduction programs. These reserves include estimates pertaining to employee separation costs and facility closure costs. Although we do not anticipate significant changes, the actual costs to settle such liabilities may differ from the amounts estimated.

 

Deferred Taxes.    We currently have significant deferred tax assets, which are subject to periodic recoverability assessments. We recorded a valuation reserve in the third quarter of 2002 against our deferred tax assets pursuant to FASB Statement No. 109, Accounting for Income Taxes (Statement 109), due to the uncertainty as to the timing and ultimate realization of those assets. As such, we did not recognize any tax benefit on the losses recorded in 2002 and recorded a valuation allowance against deferred tax assets previously recorded. For the foreseeable future, the tax provision related to earnings will be substantially offset by a

 

17


Table of Contents

reduction in the valuation reserve, and any future pretax losses will not be offset by a tax benefit due to the uncertainty of the recoverability of the deferred tax asset.

 

Realization of our deferred tax assets is principally dependent upon our achievement of future taxable income, the estimation of which requires significant management judgment. Our judgments regarding future profitability may change due to many factors, including future market conditions and our ability to successfully execute our business plans. These changes, if any, may require material adjustments to these deferred tax asset balances.

 

RESTRUCTURING AND IMPAIRMENT CHARGES

 

2002 Restructuring Plan

 

In August 2002, in response to the continued protracted downturn in the fiber optic communications market and the uncertainty with respect to the pace of recovery in the semiconductor equipment market, our Board of Directors approved management’s cost reduction plan to bring our operating costs in line with our business outlook at that time.

 

Facility Consolidations

 

As part of this cost reduction plan, we closed our Santa Ana, California fiber optics facility and consolidated those operations into our Irvine, California facility. In addition, we completed the closure of our San Luis Obispo, California facility and the consolidation of our former Design Technology facility in Billerica, Massachusetts into our MRSI facility, in North Billerica, Massachusetts. Restructuring and impairment charges for the year ended December 31, 2002 included $9.2 million for these facility consolidations. In addition, selling, general and administrative expenses for 2002 included $1.5 million of costs related to the closing of these facilities and the completion of the consolidation of our Garden Grove, California facility into our Irvine, California facility.

 

Employee Severance

 

The cost reduction plan included a workforce reduction of approximately 300 employees, of which 187 had been terminated as of December 31, 2002. Approximately one-half of the workforce reduction results from combining our automation businesses into the new Advanced Packaging and Automation Systems (APAS) division and reducing the scope of our investment in the fiber optic communications market. Approximately one-quarter of the reduction results from the divestiture of our discontinued operations, and the remaining reductions result from further streamlining of our operations. Restructuring and impairment charges for the year ended December 31, 2002 included $3.1 million for employee severance and related termination costs.

 

Inventory Reserves

 

As part of the cost reduction plan, we rationalized certain legacy products and discontinued certain product development initiatives. In addition, due to the reduced sales forecasts, we increased our reserves for slow moving inventory by $28.7 million, which is included in cost of sales for the year ended December 31, 2002. In addition, we established a reserve of $1.0 million for consignment and demonstration inventory that we deemed to be obsolete or slow moving, which is included in selling, general and administrative expenses for 2002.

 

18


Table of Contents

 

The restructuring and impairment charges, inventory reserves and other charges are classified in the accompanying consolidated statements of operations for the year ended December 31, 2002 as follows:

 

(In thousands)

  

Cost of Sales


    

Restructuring
and Impairment
Charges


      

Selling, General
and
Administrative
Expenses


  

Total


 

Inventory reserves

  

$

28,686

    

$

—  

 

    

$

—  

  

$

28,686

 

Facility consolidation and severance

  

 

—  

    

 

12,433

 

    

 

—  

  

 

12,433

 

Other non-recurring charges

  

 

—  

    

 

—  

 

    

 

2,533

  

 

2,533

 

Excess 2001 reserve

  

 

—  

    

 

(550

)

    

 

—  

  

 

(550

)

    

    


    

  


    

$

28,686

    

$

11,883

 

    

$

2,533

  

$

43,102

 

    

    


    

  


 

The restructuring and impairment charges, inventory reserves and other charges relate to the following business segments:

 

(In thousands)

    

Advanced Packaging and Automation Systems

  

$

28,967

Industrial and Scientific Technologies

  

 

13,678

Non-segment related

  

 

457

    

    

$

43,102

    

 

2001 Restructuring Plan

 

In 2001, we established restructuring reserves for the cost reduction actions implemented at that time, which included restructuring charges of $3.4 million related to workforce reductions, $9.3 million related to facility consolidations and $1.3 million related to other nonrecurring activities. In addition, we established additional reserves for excess and obsolete inventory of $24.4 million.

 

The restructuring and impairment charges, inventory reserves and other charges are classified in the accompanying consolidated statements of operations for the year ended December 31, 2001 as follows:

 

(In thousands)

  

Cost of Sales


    

Restructuring
and Impairment
Charges


    

Selling, General and
Administrative
Expenses


  

Discontinued
Operations


  

Total


Inventory reserves

  

$

22,717

    

$

—  

    

$

—  

  

$

1,676

  

$

24,393

Facility consolidation and severance

  

 

—  

    

 

11,584

    

 

—  

  

 

1,854

  

 

13,438

Other non-recurring charges

  

 

710

    

 

—  

    

 

631

  

 

—  

  

 

1,341

    

    

    

  

  

    

$

23,427

    

$

11,584

    

$

631

  

$

3,530

  

$

39,172

    

    

    

  

  

 

The restructuring and impairment charges, inventory reserves and other charges relate to the following business segments:

 

(In thousands)

    

Advanced Packaging and Automation Systems

  

$

23,545

Industrial and Scientific Technologies

  

 

8,775

Non-segment related

  

 

6,852

    

    

$

39,172

    

 

19


Table of Contents

 

The 2001 actions have been completed as of December 31, 2002, resulting in an excess restructuring reserve of $0.6 million. This amount has been used to reduce the 2002 restructuring and asset impairment charges and the related accrued restructuring costs.

 

The following table summarizes the activity in the accrued restructuring costs:

 

    

Employee Severance


    

Facility Consolidation


    

Other


    

Total


 

(In thousands)

      

Restructuring and asset impairment charges

  

$

3,216

 

  

$

7,644

 

  

$

724

 

  

$

11,584

 

Cash payments

  

 

(979

)

  

 

(46

)

  

 

(123

)

  

 

(1,148

)

Non-cash write-offs

  

 

(337

)

  

 

(4,201

)

  

 

(601

)

  

 

(5,139

)

    


  


  


  


Accrued restructuring at December 31, 2001

  

 

1,900

 

  

 

3,397

 

  

 

—  

 

  

 

5,297

 

Restructuring and asset impairment charges

  

 

3,079

 

  

 

9,151

 

  

 

203

 

  

 

12,433

 

Cash payments

  

 

(3,221

)

  

 

(1,790

)

  

 

(127

)

  

 

(5,138

)

Non-cash write-offs

  

 

—  

 

  

 

(5,872

)

  

 

(196

)

  

 

(6,068

)

Excess 2001 reserves

  

 

—  

 

  

 

—  

 

  

 

(550

)

  

 

(550

)

    


  


  


  


Accrued restructuring at December 31, 2002

  

$

1,758

 

  

$

4,886

 

  

$

(670

)

  

$

5,974

 

    


  


  


  


 

We expect to pay in cash substantially all the employee severance accrued at December 31, 2002 in 2003. The facility consolidation reserves will be paid through lease terms expiring at various dates between 2005 and 2008.

 

RESULTS OF OPERATIONS

 

Net Sales.    For 2002, 2001 and 2000, our net sales totaled $164.0 million, $290.0 million and $262.6 million, respectively. Net sales for 2002 decreased $126.0 million, or 43.4%, compared with 2001. The decrease in net sales was principally attributable to the significant downturns that continue to impact the fiber optic communications and semiconductor equipment markets, offset in part by a slight increase in sales to the aerospace and research markets. Net sales for 2001 increased $27.4 million, or 10.4%, compared with 2000, due primarily to sales increases to the semiconductor equipment market, offset in part by a decline in sales to the fiber optic communications market.

 

Sales to the semiconductor equipment market were $61.0 million, $86.6 million and $67.4 million for 2002, 2001 and 2000, respectively. Sales to this market in 2002 decreased $25.6 million, or 29.6%, compared with 2001, reflecting weakness in demand by semiconductor manufacturers for capital equipment, which led to a significant reduction in demand for the components, subsystems and robots we sell to this market. In 2001, sales to this market increased $19.2 million, or 28.5%, compared with 2000. The sales increase in 2001 compared with 2000 reflected the strong demand by semiconductor manufacturers for capital equipment through the second quarter of 2001, offset in part by a substantial decline in this market during the second half of 2001.

 

Sales to the research and aerospace, life and health sciences and related industrial markets were $86.0 million, $101.2 million and $84.5 million for 2002, 2001 and 2000, respectively. Sales to these markets in 2002 decreased $15.2 million, or 15.0%, compared with 2001. Sales to research and aerospace customers during 2002 were higher compared with 2001, but this increase was offset by a significant reduction in sales to industrial customers supporting the telecommunications industry. In 2001, sales to this market increased $16.7 million, or 19.8%, compared with 2000, due primarily to increased sales to industrial customers supporting the telecommunications industry.

 

Sales to the fiber optic communications market were $17.0 million, $102.2 million and $110.7 million for 2002, 2001 and 2000, respectively. Sales to this market in 2002 decreased $85.2 million, or 83.4%, compared with 2001, reflecting the continued severe market downturn in capital spending in this market. Sales to this

 

20


Table of Contents

market in 2001 decreased $8.5 million, or 7.7%, compared with 2000, as we began experiencing weak market demand during the second half of 2001.

 

For 2002, 2001 and 2000, domestic sales were $116.2 million, $201.7 million and $181.4 million, respectively. Domestic sales in 2002 decreased $85.5 million, or 42.4%, compared with 2001, due to sales decreases in the fiber optic communications, semiconductor equipment and other markets of $51.2 million, or 83.8%, $25.6 million, or 31.0%, and $8.7 million, or 15.0%, respectively. Domestic sales in 2001 increased $20.3 million, or 11.2%, compared with 2000, due primarily to sales increases in the semiconductor equipment and other markets of $20.3 million, or 32.5%, and $10.9 million, or 23.2%, respectively, offset in part by a decline in sales to the fiber optic communications market of $10.9 million, or 15.1%.

 

International sales totaled $47.8 million, $88.3 million and $81.2 million for 2002, 2001 and 2000, respectively. For 2002, international sales decreased $40.5 million, or 45.9%, compared with 2001, due primarily to decreases in the fiber optic communications market and the research and aerospace, life and health sciences and related industrial markets of $34.0 million, or 82.7%, and $6.5 million, or 15.0%, respectively. Geographically, the decrease in 2002 sales compared with 2001 was driven by reductions in sales of $25.8 million, or 46.4%, to European customers, $5.6 million, or 29.8%, to Pacific Rim customers, $7.8 million, or 74.3%, to Canadian customers, and $1.3 million, or 38.2%, to other international customers. The increase in international sales in 2001 compared with 2000 of $7.1 million, or 8.7%, was due primarily to increases in the fiber optic communications market and the research and aerospace, life and health sciences and related industrial markets of $2.4 million, or 6.2%, and $5.8 million, or 15.5%, respectively. This increase was offset in part by a decrease in international sales to the semiconductor equipment market of $1.1 million or 22.0%. Geographically, the increase in 2001 sales compared with 2000 was driven primarily by sales to European and other international customers of $16.4 million, or 41.8% and $1.2 million or 54.5%, respectively, offset in part by lower sales to Canadian and Pacific Rim customers of $4.8 million, or 31.4% and $5.7 million, or 23.3%, respectively.

 

Our business is subject to risks arising from market conditions in the semiconductor equipment and fiber optic communications markets, as well as from general economic conditions. During the second half of 2001, the semiconductor equipment and fiber optic communications markets experienced severe downturns. Additionally, the general economic recession constrained capital spending in many of our end markets. The downturn in the fiber optic communications market continued and worsened in 2002, and we expect orders from and sales to this market to remain depressed through 2003 and into 2004. The semiconductor equipment market recovered slightly in the second and third quarters of 2002, but that recovery stalled, and we expect the recovery in this market to be delayed until later in 2003. The precise timing and extent of any recovery from these conditions in the semiconductor equipment and fiber optic communications markets is difficult to predict and represents a significant uncertainty with respect to our future operating results. We expect that our sales to the aerospace and defense and research markets will fluctuate from period to period in line with changes in overall research and defense spending levels, but will show a long-term growth trend in line with growth in the United States gross domestic product.

 

Gross Margin.    Gross margin was 15.7%, 33.5% and 47.2% for 2002, 2001 and 2000, respectively. The reductions in gross margin for 2002 and 2001 resulted primarily from charges recorded in the third quarter of each year of $28.7 million and $22.7 million, respectively, for excess inventory related primarily to continued weakness in the telecommunications industry. (See “Restructuring And Impairment Charges” on pages 18-20). Excluding these charges, gross margin would have been 33.2% in 2002 and 41.4% in 2001. The reduction in gross margin for 2002 also resulted from significantly lower sales volume and lower fixed overhead absorption in 2002, offset in part by lower sales to OEM customers. The decrease in gross margin in 2001 compared with 2000 was due primarily to the charge described above, as well as to lower absorption of fixed overhead caused by the sharp decline in sales volume through the second half of 2001.

 

Generally, we expect that our gross margin will fluctuate in future periods due to factors including absorption of fixed overhead due to sales volumes and production activity, product mix and the proportion of

 

21


Table of Contents

sales to OEM customers, material costs, changes in the carrying value of inventory and manufacturing efficiencies. Because a significant portion of our manufacturing overhead is fixed in the short term, the impact of increases or decreases in sales on our gross margin will likely not be in proportion to the changes in sales.

 

Selling, General and Administrative (SG&A) Expense.    SG&A expense totaled $50.2 million, or 30.6% of net sales, $57.3 million, or 19.8% of net sales, and $51.5 million, or 19.6% of net sales, for 2002, 2001 and 2000, respectively. SG&A expense for 2002 included expenses in the third quarter of $2.5 million for costs incurred in connection with our cost reduction initiatives. Excluding these charges, SG&A expense for 2002 would have been $47.7 million, or 29.1% of sales. The expense decrease on a year-over-year basis resulted from lower variable expenses related to the lower sales volume and from the benefits of our cost reduction measures, offset in part by the addition of SG&A expenses relating to our MRSI subsidiary, acquired in February 2002, for which there was no comparable expense in the 2001 periods. SG&A expense for 2001 and 2000 included $2.5 million and $1.1 million, respectively, for amortization of goodwill. Pursuant to FASB Statement No. 142, Goodwill and Other Intangible Assets, beginning in 2002, goodwill is no longer required to be amortized, but instead is subject to periodic impairment testing. SG&A expenses in 2001 increased $5.8 million, or 11.3%, compared with 2000, primarily due to costs of the additional infrastructure added to be able to support the sales growth forecasted in late 2000 and early 2001, offset in part by the effects of the cost reduction efforts initiated in the second half of 2001 in response to the downturn in our primary end markets.

 

We expect that SG&A as a percentage of sales will fluctuate in the future based on our sales level in any given period. Because a significant portion of our SG&A expenses are fixed in the short term, these fluctuations will likely not be in proportion to the change in sales.

 

Research and Development (R&D) Expense.    R&D expense totaled $24.4 million, or 14.9% of net sales, $26.1 million, or 9.0% of net sales, and $21.7 million, or 8.3% of net sales, for 2002, 2001 and 2000, respectively. R&D expense decreased $1.7 million, or 6.5%, in 2002 compared with 2001 due primarily to our efforts to maximize the focus and efficiency of our R&D efforts, offset by additional R&D spending related to MRSI, for which there was no comparable expense in 2001. R&D expense increased $4.4 million, or 20.3%, in 2001 compared with 2000 due primarily to increased personnel costs related to the development of a number of new products and product enhancements, primarily in our APAS division.

 

We believe that the continued development and advancement of our key products and technologies is critical to our future success. Accordingly, we intend to continue to invest in key R&D initiatives, while working to ensure that the efforts are focused and the funds are deployed efficiently. We expect that R&D expense as a percentage of sales will fluctuate in the future based on our sales level in any given period. Because of our commitment to continued product development, and because a significant portion of our R&D expense are fixed in the short term, these fluctuations will likely not be in proportion to the change in sales.

 

Restructuring and Impairment Charges.    Restructuring and impairment charges related to the cost reduction and related initiatives discussed previously totaled $11.9 million for 2002 and $11.6 million in 2001.

 

Acquisition and Other Non-Recurring Charges.    During the first quarter of 2001, we recorded acquisition and other non-recurring charges of $10.7 million. These charges were comprised of $9.2 million for investment banking, legal and accounting fees related to our acquisition of KLI and a charge of $1.5 million related to the acceleration of stock options held by a retiring executive officer.

 

Interest and Other Income, Net.    Interest and other income, net of interest expense, totaled $10.3 million, $13.8 million and $6.0 million for 2002, 2001 and 2000, respectively. The decrease in 2002 from 2001 was due primarily to realized losses on foreign exchange transactions and reduced interest rate levels during 2002. In the third quarter of 2000, we completed a secondary public offering for which we received proceeds of $329.9 million (after underwriting discounts and commissions). The increase in 2001 compared with 2000 was primarily attributable to income from the investment of the proceeds from the secondary offering for the full year 2001.

 

22


Table of Contents

 

We expect that interest income will fluctuate in future periods based on cash balances and changes in interest rates and foreign exchange rates.

 

Asset Write-Down.    Two fiber optic component manufacturers in which we had made minority investments in prior years experienced severe financial difficulties during 2002. One manufacturer has shut down its operations and liquidated its assets and the second manufacturer filed for bankruptcy protection. As a result, we wrote-down these investments to their estimated fair value, resulting in a charge of $6.5 million during 2002.

 

Income Taxes.    Our effective tax rates from continuing operations were (24.6%), 35.7% and 22.7% for 2002, 2001 and 2000, respectively. The 2002 tax expense resulted from a valuation allowance that was recorded against a portion of our deferred tax assets pursuant to Statement 109, due to the uncertainty as to the timing and ultimate realization of those assets. As such, we did not recognize any tax benefit on the losses recorded in the current period and recorded a $52.8 million valuation allowance against deferred tax assets previously recorded. For the foreseeable future, the tax provision related to earnings will be substantially offset by a reduction in the valuation reserve, and any future pretax losses will not be offset by a tax benefit due to uncertainty of the recoverability of the deferred tax asset.

 

The increase in our effective tax rate in 2001 compared with 2000 was due primarily to the earnings attributable to our acquisition of KLI, which was accounted for as a pooling of interests. Prior to its acquisition, KLI was treated as an S-corporation for U.S. tax purposes and accordingly, recorded no income tax provision. Assuming that KLI had been taxed as a C-corporation for all periods presented, our effective tax rate in 2000 would have been 32.6%.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Despite our net loss of $100.6 million, our operating activities in 2002 provided cash of $6.5 million. Cash provided by operations was primarily attributable to a decrease in other current assets of $3.3 million and collections of customer receivables of $14.8 million, offset in part by a decrease in accounts payable and accrued expenses of $13.7 million.

 

Net cash provided by investing activities of $31.3 million for 2002 was primarily attributable to net sales of marketable securities of $36.6 million and the proceeds from the sale of businesses of $9.9 million, partially offset by purchases of property, plant and equipment ($6.7 million) and net cash paid and cash expenses relating to our acquisitions of MRSI ($6.5 million) and certain intellectual property rights ($2.0 million).

 

Net cash used in financing activities in 2002 of $1.6 million was primarily attributable to payments on long-term borrowings of $6.6 million, offset in part by the sales of common stock in connection with stock option exercises and employee stock purchase plans, which generated $5.0 million in proceeds and resulted in the issuance of approximately 870,000 shares of common stock.

 

At December 31, 2002, we had cash, cash equivalents and marketable securities of $284.3 million. Substantially all of our marketable securities are divided into three portfolios, each managed by a professional investment management firm, under the oversight of the Investment Committee of our Board of Directors and members of our senior management team. Such portfolio managers invest the funds allocated to them in accordance with our Investment Policy, which is reviewed regularly by the Investment Committee and our senior financial management. We expect that our portfolio balances will fluctuate in the future based on factors such as cash used in or provided by ongoing operations, acquisitions or divestitures, investments in other companies, capital expenditures and contractual obligations, as well as changes in interest rates and foreign exchange rates.

 

At December 31, 2002, we had in place a credit agreement for a $5.0 million unsecured line of credit expiring September 1, 2003. Certain of the marketable securities that are being managed by the lending institution collateralize the line of credit. The line bears interest at the prevailing prime rate, or the prevailing

 

23


Table of Contents

London Interbank Offered Rate plus 1.5%, at our option, plus an unused line fee of 0.25% per year. At December 31, 2002, there were no balances outstanding under the line of credit, with $4.5 million available under the line, after considering outstanding letters of credit totaling $0.5 million.

 

At December 31, 2002, we had $3.0 million outstanding under a long-term debt agreement with an insurance company. These unsecured senior notes, sold at par, carry an 8.25% annual coupon and mature in May 2004. Principal and interest are payable semiannually. At December 31, 2002, we were not in compliance with a covenant under this agreement due to the net loss and the restructuring and impairment charges recorded in 2002. The insurance company has waived this noncompliance through December 31, 2002 and has amended the debt agreement effective December 31, 2002 to delete this covenant. We believe we will be in compliance with our other debt covenants on an ongoing basis.

 

We lease certain of our manufacturing and office facilities and equipment under non-cancelable operating leases.

Contractual obligations at December 31, 2002 are summarized as follows:

 

(In thousands)

  

Payments Due By Period


    

Total


  

2003


  

2004


  

2005


  

2006


  

2007 and beyond


Operating lease obligations

  

$

33,679

  

$

6,899

  

$

5,450

  

$

4,979

  

$

3,572

  

$

12,779

Principal payments on long-term debt

  

 

3,444

  

 

2,214

  

 

1,168

  

 

62

  

 

—  

  

 

—  

    

  

  

  

  

  

    

$

37,123

  

$

9,113

  

$

6,618

  

$

5,041

  

$

3,572

  

$

12,779

    

  

  

  

  

  

 

We believe our current working capital position together with estimated cash flows from operations and existing credit availability are adequate to fund operations in the ordinary course of business, anticipated capital expenditures, debt payment requirements and other contractual obligations, for the foreseeable future. However, this belief is based upon many assumptions and is subject to numerous risks (see “Risks Relating To Our Business,” on pages 26-32), and there can be no assurance that we will not require additional funding in the future.

 

Although we have no present agreements or commitments with respect to any material acquisitions of other businesses, products, product rights or technologies, we continue to evaluate acquisitions of and/or investments in products, technologies or companies that complement our business and may make such acquisitions in the future. Accordingly, there can be no assurance that we will not need to obtain additional sources of capital in the future to finance any such acquisitions.

 

NEW ACCOUNTING STANDARDS

 

In November 2002, the Financial Accounting Standards Board (FASB) issued Interpretation No. 45, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others (FIN 45), effective prospectively for guarantees issued or modified after December 31, 2002. The disclosure requirements of FIN 45 are effective for periods ending after December 15, 2002. Under FIN 45, a guarantor is required to recognize, at the inception of certain guarantees, a fair value liability for the obligations it has undertaken in issuing the guarantee, including its ongoing obligation to stand ready to perform over the term of the guarantee in the event that the specified triggering events or conditions occur. FIN 45 clarifies that a guarantor is required to disclose (a) the nature of the guarantee, including the term and circumstances giving rise to the guarantee; (b) the maximum potential amount of future payments under the guarantee; (c) the carrying amount of the liability, if any, for the guarantor’s obligation under the guarantee; and (d) the nature and extent of any recourse or collateral provisions. All guarantees subject to the disclosure provisions of FIN 45, such as product warranties, have been disclosed in the Notes to the Consolidated Financial

 

24


Table of Contents

Statements included in this Annual Report on Form 10-K. We do not have any other outstanding guarantees at December 31, 2002 that would be required to be disclosed or recorded as obligations upon adoption of FIN 45.

 

On January 1, 2002, we adopted FASB Statement No. 141, Business Combinations (Statement 141). Statement 141 eliminates the pooling of interests method of accounting for business combinations and changed the criteria to recognize intangible assets apart from goodwill. We accounted for the acquisition of MRSI in accordance with the provisions of Statement 141.

 

On January 1, 2002, we adopted FASB Statement No. 142, Goodwill and Other Intangible Assets (Statement 142). Under Statement 142, goodwill is no longer amortized but is subject to impairment tests based upon a comparison of the fair value of each of our reporting units, as defined, and the carrying value of the reporting units’ net assets, including goodwill. Pursuant to Statement 142, upon adoption we tested our goodwill for impairment and recorded an impairment charge of $14.5 million as the cumulative effect of a change in accounting principle on January 1, 2002. Statement 142 requires a review for impairment at least annually or when circumstances exist that would indicate an impairment of such goodwill. We perform the annual impairment review as of October 1 of each year. The October 2002 annual review indicated no further impairment of the carrying value of our goodwill. At December 31, 2002, we had goodwill of approximately $57.5 million. Had we not amortized goodwill, our net loss from continuing operations for the year ended December 31, 2001 would have decreased $2.5 million and our net income from continuing operations for the year ended December 31, 2000 would have increased $1.1 million.

 

On January 1, 2002, we adopted FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (Statement 144). Under Statement 144, long-lived assets, other than goodwill, are evaluated for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. In addition, assets held for sale are included in discontinued operations if the operations and cash flows will be or have been eliminated from the ongoing operations of the entity and the entity will not have any significant continuing involvement in the operations of the component. The discontinuances of our Industrial Metrology Systems Division and our Plymouth, Minnesota facility have been accounted for as discontinued operations under the provisions of Statement 144.

 

In July 2002, the FASB issued Statement No. 146, Accounting for Costs Associated with Exit or Disposal Activities (Statement 146). Statement 146 addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring) (EITF 94-3). Statement 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred. Statement 146 is effective for exit or disposal activities that are initiated after December 31, 2002. Because our cost reduction and other initiatives occurred prior to December 31, 2002, they have been accounted for under EITF 94-3, and the associated cost has been recognized as of the date of the Board of Directors’ approval of management’s cost reduction plan. If any restructuring activities are undertaken in future years, they will be accounted for under Statement 146.

 

In December 2002, the FASB issued Statement No. 148, Accounting for Stock-Based Compensation—Transition and Disclosure (Statement 148), providing alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, Statement 148 amends the disclosure requirements to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. We do not currently plan to change our stock-based employee compensation accounting to the fair value method. The accompanying consolidated financial statements reflect all of the disclosures required by Statement 148.

 

25


Table of Contents

 

RISKS RELATING TO OUR BUSINESS

 

Our operating results are difficult to predict, and if we fail to meet the expectations of investors and/or securities analysts, the market price of our common stock will likely decline significantly.

 

Our operating results in any given quarter have fluctuated and will likely continue to fluctuate. These fluctuations are typically unpredictable and can result from numerous factors including:

 

    fluctuations in our customers’ capital spending, industry cyclicality and other economic conditions within the markets we serve;

 

    demand for our products and the products sold by our customers;

 

    the level of orders within a given quarter and preceding quarters;

 

    the timing and level of cancellations and delays of orders for our products;

 

    the timing of product shipments within a given quarter;

 

    our timing in introducing new products;

 

    variations in the mix of products we sell in each of the markets in which we do business;

 

    changes in our pricing policies or in the pricing policies of our competitors or suppliers;

 

    market acceptance of any new or enhanced versions of our products;

 

    the availability and cost of key components and raw materials we use to manufacture our products;

 

    our ability to manufacture a sufficient quantity of our products to meet customer demand;

 

    fluctuations in foreign currency exchange rates;

 

    timing of new product introductions by our competitors; and

 

    our levels of expenses.

 

We may in the future choose to reduce prices, increase spending, or add or eliminate products in response to actions by competitors or in an effort to pursue new market opportunities. These actions may also adversely affect our business and operating results and may cause our quarterly results to be lower than the results of previous quarters. We believe that quarter-to-quarter comparisons of results from operations, or any other similar period-to-period comparisons, should not be construed as reliable indicators of our future performance. In any period, our results may be below the expectations of market analysts and investors, which would likely cause the trading price of our common stock to drop.

 

We are highly dependent on the semiconductor industry and on our customers who serve this volatile and unpredictable industry.

 

A substantial portion of our current and expected future business comes from sales of subsystem products to manufacturers of semiconductor fabrication and metrology equipment and sales of capital equipment to integrated semiconductor device manufacturers. The semiconductor market has historically been characterized by sudden and severe cyclical variations in product supply and demand. The timing, severity and duration of these market cycles are difficult to predict, and we may not be able to respond effectively to these cycles. The continuing uncertainty in this market severely limits our ability to predict our business prospects or financial results in this market.

 

During industry downturns, our revenues from this market may decline suddenly and significantly. Our ability to rapidly and effectively reduce our cost structure in response to such downturns is limited by the fixed nature of many of our expenses in the near term and by our need to continue our investment in next-generation product technology and to support and service our products. In addition, due to the relatively long manufacturing

 

26


Table of Contents

lead times for some of the systems and subsystems we sell to this market, we may incur expenditures or purchase raw materials or components for products we cannot sell. Accordingly, downturns in the semiconductor capital equipment market may materially harm our operating results. Conversely, when upturns in this market occur, we must be able to rapidly and effectively increase our manufacturing capacity to meet increases in customer demand that may be extremely rapid, and if we fail to do so we may lose business to our competitors and our relationships with our customers may be harmed.

 

The semiconductor capital equipment market is characterized by rapid technological change, frequent product introductions, changing customer requirements and evolving industry standards. Because our customers face uncertainties with regard to the growth and requirements of these markets, their products and components may not achieve, or continue to achieve, anticipated levels of market acceptance. If our customers are unable to deliver products that gain market acceptance, it is likely that these customers will not purchase our products or will purchase smaller quantities of our products. We often invest substantial resources in developing our systems and subsystems in advance of significant sales of these systems and/or subsystems to such customers. A failure on the part of our subsystem customers’ products to gain market acceptance, or a failure of the semiconductor capital equipment market to grow would have a significant negative effect on our business and results of operations.

 

We rely on a limited number of customers for a significant portion of our sales to the semiconductor capital equipment market. Our top five customers in this market comprised approximately 75.2% and 61.1% of our sales to this market in the fiscal year ended December 31, 2002 and 2001, respectively, and our top two customers accounted for approximately 54.3% and 38.5%, respectively, of our sales to this market in these periods. In 2002, one customer in this market, Applied Materials, Inc., comprised 10.9% of our consolidated net sales for the year. If any of our principal customers discontinues its relationship with us, replaces us as a subsystem vendor for certain products or suffers downturns in its business, our business and results of operations could be harmed significantly. In addition, because a relatively small number of semiconductor capital equipment manufacturers dominate this market, it may be particularly difficult for us to replace our customers if we lose their business.

 

A significant portion of our expected future subsystem business in the semiconductor capital equipment market is comprised of products for the fabrication of 300mm semiconductor wafers. Wafer fabrication equipment for 300mm wafers is in a very early stage of its adoption, and is expected to be driven by the need for the ability to manufacture more semiconductor chips at lower cost. The deployment of such equipment requires a significant capital investment by semiconductor manufacturers, and many semiconductor manufacturers have delayed plans to deploy such equipment until market conditions improve. If the demand for capital equipment for 300mm wafers does not increase, or increases more slowly than expected, demand for our subsystem products will likewise be adversely affected, and our business and results of operations could be harmed significantly.

 

In addition, a significant portion of our expected future capital equipment sales to the integrated semiconductor device manufacturing market is comprised of systems for flip chip bonding and other advanced die bonding techniques. Demand for these systems is expected to be driven in significant part by increases in demand for new technologies in industries such as communications and consumer electronics that require the use of such manufacturing techniques. If the demand for electronic devices requiring flip chip bonding and/or other advanced die bonding techniques does not increase, or increases more slowly than expected, demand for our capital equipment will likewise be adversely affected, and our business and results of operations could be harmed significantly.

 

Many of the markets and industries that we serve are subject to rapid technological change, and if we do not introduce new and innovative products or improve our existing products, our business and results of operations will be negatively affected.

 

Many of our markets are characterized by rapid technological advances, evolving industry standards, shifting customer needs and new product introductions and enhancements. Products in our markets often become

 

27


Table of Contents

outdated quickly and without warning. We depend to a significant extent upon our ability to enhance our existing products, to address the demands of the marketplace for new and improved technology, either through internal development or by acquisitions, and to be price competitive. If we or our competitors introduce new or enhanced products, it may cause our customers to defer or cancel orders for our existing products. In addition, because certain of our markets experience severe cyclicality in capital spending, if we fail to introduce new products in a timely manner we may miss market upturns, and may fail to have our subsystem products designed into our customers’ products. We may not be successful in acquiring, developing, manufacturing or marketing new products on a timely or cost-effective basis. If we fail to adequately introduce new, competitive products on a timely basis, our business and results of operations would be harmed.

 

We offer products for multiple industries and must face the challenges of supporting the distinct needs of each of the markets we serve.

 

We market products for the semiconductor capital equipment, aerospace and defense, life and health sciences, scientific research and fiber optic communications markets. Because we operate in multiple markets, we must work constantly to understand the needs, standards and technical requirements of several different industries and must devote significant resources to developing different products for these industries. Product development is costly and time consuming. Many of our products are used by our customers to develop, manufacture and test their own products. As a result, we must anticipate trends in our customers’ industries and develop products before our customers’ products are commercialized. If we do not accurately predict our customers’ needs and future activities, we may invest substantial resources in developing products that do not achieve broad market acceptance. Our decision to continue to offer products to a given market or to penetrate new markets is based in part on our judgment of the size, growth rate and other factors that contribute to the attractiveness of a particular market. If our product offerings in any particular market are not competitive or our analyses of a market are incorrect, our business and results of operations would be harmed.

 

Because the sales cycle for some of our products is long and difficult to predict, and certain of our orders are subject to rescheduling or cancellation, we may experience fluctuations in our operating results.

 

Many of our capital equipment and subsystem products are complex, and customers for these products require substantial time to make purchase decisions. These customers often perform, or require us to perform extensive configuration, testing and evaluation of our products before committing to purchasing them. The sales cycle for our capital equipment and subsystem products from initial contact through shipment typically varies, is difficult to predict and can last as long as one year. The orders comprising our backlog are often subject to cancellation and changes in delivery schedules by our customers without significant penalty. We have from time to time experienced order rescheduling and cancellations that have caused our revenues in a given period to be materially less than would have been expected based on our backlog at the beginning of the period. If we experience such rescheduling and/or cancellations in the future, our operating results will fluctuate from period to period. These fluctuations could harm our results of operations and cause our stock price to drop.

 

The severe downturn in the fiber optic communications market has harmed and may continue to harm our business.

 

Our sales to the fiber optic communications market are largely dependent upon sales to companies that manufacture components for fiber optic communications systems. These component manufacturers are largely dependent upon telecommunications system manufacturers, who in turn depend on sales of their products to telecommunications carriers. As such, our success in this market will ultimately depend on the long-term growth of the communications industry, and in particular the growth of Internet usage and bandwidth demand. Demand for high-bandwidth service has not grown as quickly as the communications industry had forecast, and many carriers currently have significant excess capacity in their fiber optic networks. As a result, demand for optical components has decreased substantially, leaving many component manufacturers with significant excess manufacturing capacity. Unless and until higher demand for bandwidth increases network utilization and

 

28


Table of Contents

bandwidth pricing, telecommunications carriers will be unlikely to make significant investments in new fiber optic networks, and sales of the manufacturing and test equipment we supply to the companies that build this network equipment will be unlikely to increase significantly. In addition, several major telecommunications carriers have recently declared bankruptcy or are in significant financial distress, and others have significant debt service obligations that may limit their ability to purchase new network equipment, which may further delay the recovery of this market.

 

Due to the decline in demand for optical components and our customers’ significant excess manufacturing capacity, our sales to this market have declined substantially, and may decline further in the future. While we have significantly reduced the cost structure of our operations serving this market, our ability to reduce these costs further is limited by our plans to continue our investment in certain critical next-generation product technology and to support and service our products. In addition, due to the relatively long manufacturing lead times for some of the systems and subsystems we sell to these markets, we may incur expenditures or purchase raw materials or components for products we cannot sell. We have in the past and may in the future be required to write off excess or obsolete inventory due to declines in our forecasted sales to this market.

 

Our component manufacturer customers have experienced severe business declines during this downturn. Several of these customers have recently ceased operations or announced their intent to exit this market. Others are currently operating at losses and are unable to make meaningful long-term predictions for their recovery, and hence their forecasted requirements for capital equipment. This continuing uncertainty severely limits our ability to predict the timing of any recovery in this market or our sales to this market in future periods.

 

We face significant risks from doing business in foreign countries.

 

Our business is subject to risks inherent in conducting business internationally. In 2002, 2001 and 2000, our international revenues accounted for approximately 29.1%, 30.4% and 30.9%, respectively, of total net sales, with a substantial portion of sales originating in Europe. We expect that international revenues will continue to account for a significant percentage of total net sales for the foreseeable future. As a result of our international operations, we face various risks, which include:

 

    adverse changes in the political or economic conditions in countries or regions where we manufacture or sell our products;

 

    challenges of administering our business globally;

 

    compliance with multiple and potentially conflicting regulatory requirements including export requirements, tariffs and other trade barriers;

 

    longer accounts receivable collection periods;

 

    overlapping, differing or more burdensome tax structures;

 

    adverse currency fluctuations;

 

    differing protection of intellectual property;

 

    difficulties in staffing and managing each of our individual foreign operations; and

 

    trade restrictions and licensing requirements.

 

As a result of our international operations, fluctuations in foreign exchange rates could affect the sales price in local currencies of our products in foreign markets, potentially making our products less competitive. In addition, exchange rate fluctuations could increase the costs and expenses of our foreign operations or require us to modify our current business practices. If we experience any of the risks associated with international business, our business and results of operations could be significantly harmed.

 

29


Table of Contents

 

We face substantial competition, and if we fail to compete effectively, our operating results will suffer.

 

The markets for our products are intensely competitive, and we believe that competition from both new and existing competitors will increase in the future. We compete in several specialized markets, against a limited number of companies in each market. We also face competition in some of our markets from our existing and potential customers who have developed or may develop products that are competitive to ours. Many of our existing and potential competitors are more established, enjoy greater name recognition and possess greater financial, technological and marketing resources than we do. Other competitors are small and highly specialized firms that are able to focus on only one aspect of a market. We compete on the basis of product features, quality, reliability and price and on our ability to manufacture and deliver our products on a timely basis. We may not be able to compete successfully in the future against existing or new competitors. In addition, competitive pressures may force us to reduce our prices, which could negatively affect our operating results. If we do not respond adequately to competitive challenges, our business and results of operations would be harmed.

 

Acquisitions of additional businesses, products or technologies we may make could negatively affect our business.

 

We have historically achieved growth through a combination of internally developed new products and acquisitions. In recent years we have acquired several companies and technologies, and we expect to continue to pursue acquisitions of other companies, technologies and complementary product lines in the future to expand our product offerings and technology base to further our strategic goals. Each of our recent acquisitions involves, and any future acquisition would involve risks, including:

 

    a decline in demand by our customers for the products of the acquired business;

 

    our ability to integrate the acquired business’ operations, products and personnel;

 

    our ability to retain key personnel of the acquired businesses;

 

    our ability to manufacture and sell the products of the acquired businesses;

 

    our ability to expand our financial and management controls and reporting systems and procedures to integrate the acquired businesses;

 

    our ability to realize expected synergies resulting from the acquisition;

 

    diversion of management’s time and attention;

 

    customer dissatisfaction or performance problems with the products or services of an acquired firm;

 

    assumption of unknown liabilities, or other unanticipated events or circumstances; and

 

    the need to record significant charges or write down the carrying value of intangible assets, which could lower our earnings.

 

We cannot assure that any business that we may acquire will achieve anticipated revenues and operating results. Any of these risks could materially harm our business, financial condition and results of operations.

 

If we are delayed in introducing our new products into the marketplace, or if our new products contain defects, our operating results will suffer.

 

Because certain of our products are sophisticated and complex, we may experience delays in introducing new products or enhancements to our existing products. If we do not introduce our new products or enhancements into the marketplace in a timely fashion, our customers may choose to use competitors’ products. Our inability to introduce new or enhanced products in a timely manner could cause our business and results of operations to suffer. Our products may also contain defects or undetected errors. As a result, we could incur substantial expenses in fixing any defects or undetected errors, which could result in damage to our competitive position and harm our business and results of operations.

 

30


Table of Contents

 

If we are unable to attract new employees and retain and motivate existing employees, our business and results of operations will suffer.

 

Our ability to maintain and grow our business is directly related to the service of our employees in each area of our operations. Our future performance will be directly tied to our ability to hire, train, motivate and retain qualified personnel. Competition for personnel in the technology marketplace is intense, and if we are unable to hire sufficient numbers of employees with the experience and skills we need or to retain our employees, our business and results of operations would be harmed.

 

If we fail to protect our intellectual property and proprietary technology, we may lose our competitive advantage.

 

Our success and ability to compete depend in large part upon protecting our proprietary technology. We rely on a combination of patent, trademark and trade secret protection and nondisclosure agreements to protect our proprietary rights. The steps we have taken may not be sufficient to prevent the misappropriation of our intellectual property, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. The patent and trademark law and trade secret protection may not be adequate to deter third party infringement or misappropriation of our patents, trademarks and similar proprietary rights. In addition, patents issued to us may be challenged, invalidated or circumvented. Our rights granted under those patents may not provide competitive advantages to us, and the claims under our patent applications may not be allowed. We may be subject to or may initiate interference proceedings in the United States Patent and Trademark Office, which can demand significant financial and management resources. The process of seeking patent protection can be time consuming and expensive and patents may not be issued from currently pending or future applications. Moreover, our existing patents or any new patents that may be issued may not be sufficient in scope or strength to provide meaningful protection or any commercial advantage to us. We may in the future initiate claims or litigation against third parties for infringement of our proprietary rights in order to determine the scope and validity of our proprietary rights or the proprietary rights of our competitors, which claims could result in costly litigation and the diversion of our technical and management personnel. For example, we have notified several manufacturers of semiconductor wafer handling robots and load ports that we believe that they are infringing upon certain of our U.S. patents. We will take such actions where we believe that they are of sufficient strategic or economic importance to us to justify the cost.

 

We have experienced, and may in the future experience, intellectual property infringement claims.

 

We have from time to time received communications from third parties alleging that we are infringing certain trademarks, patents or other intellectual property rights of others. For example, Newport Electronics, Inc., a manufacturer of electronic devices, filed suit against us claiming that our use of the “Newport” trademark infringes its rights with respect to such mark. In addition, we periodically receive correspondence from third parties alleging that certain of our products infringe patent rights held by them. Whenever claims arise, we evaluate their merits. Any claims of infringement brought by third parties could result in protracted and costly litigation, and we could become subject to damages for infringement, or to an injunction preventing us from selling one or more of our products or using one or more of our trademarks. Such claims could also result in the necessity of obtaining a license relating to one or more of our products or current or future technologies, which may not be available on commercially reasonable terms or at all. Any intellectual property litigation and the failure to obtain necessary licenses or other rights could have a material adverse effect on our business, financial condition and results of operations. In addition, the terms of our customer contracts typically require us to indemnify the customer in the event of any claim of infringement brought by a third party based on our products. Any such claims of this kind may have a material adverse effect on our business, financial condition or results of operations.

 

31


Table of Contents

 

We rely on several sole-source and limited source suppliers.

 

We obtain some of the materials used to build our systems and subsystems, such as the sheet steel used in some of our vibration isolation tables, from single or limited sources due to unique component designs as well as specialized quality and performance requirements needed to manufacture our products. If our components or raw materials are unavailable in adequate amounts or are unavailable on satisfactory terms, we may be required to purchase them from alternative sources, if available, which could increase our costs and cause delays in the production and distribution of our products. If we do not obtain comparable replacement components from other sources in a timely manner, our business and results of operations will be harmed. Many of our suppliers require long lead-times to deliver the quantities of components that we need. If we fail to accurately forecast our needs, or if we fail to obtain sufficient quantities of components that we use to manufacture our products, then delays or reductions in production and shipment could occur, which would harm our business and results of operations.

 

Terrorism and acts of war and the associated economic uncertainties may negatively impact our business.

 

Terrorist attacks and potential military activities have created economic and political uncertainties, contributing to the current global economic downturn. Future acts of terrorism or increased military action may create additional uncertainties and worsen or delay recovery of the global economy, which could negatively impact our business, financial condition or results of operations.

 

Natural disasters could disrupt or shut down our operations.

 

Our operations are susceptible to damages from earthquakes, floods, fire, loss of power or water supplies, or other similar contingencies. We have significant facilities in areas with above average seismic activity. If any of our facilities were to experience a catastrophic loss, it could disrupt our operations, delay production, shipments and revenue, and result in large expenses to repair or replace the facility, any of which would harm our business. We are predominantly uninsured for losses and interruptions caused by earthquakes.

 

Item 7A.    Quantitative and Qualitative Disclosures About Market Risk

 

The principal market risks (i.e., the risk of loss arising from adverse changes in market rates and prices) to which we are exposed are foreign exchange rates which may generate translation and transaction gains and losses and interest rate risk.

 

Foreign Currency Risk

 

Operating in international markets sometimes involves exposure to volatile movements in currency exchange rates. The economic impact of currency exchange rate movements on our operating results is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions and other factors. These changes, if material, may cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

 

We use forward exchange contracts to mitigate the risks associated with certain foreign currency transactions entered into in the ordinary course of business, primarily foreign currency denominated receivables. We do not engage in currency speculation. The forward exchange contracts generally require us to exchange U.S. dollars for foreign currencies at maturity, at rates agreed to at inception of the contracts. If the counterparties to the exchange contracts (AA or A+ rated banks) do not fulfill their obligations to deliver the contracted currencies, we could be at risk for any currency related fluctuations. Transaction gains and losses are included in current earnings. Foreign exchange contracts totaled $0.4 million at December 31, 2002. Net foreign exchange gains and losses were not material to our earnings for the last three years.

 

32


Table of Contents

 

Operating profit from international operations totaled $0.02 million and $12.6 million for 2002 and 2001, respectively. As currency exchange rates change, translation of the income statements of international operations into U.S. dollars affects year-over-year comparability of operating results. We do not generally hedge translation risks because cash flows from international operations are generally reinvested locally. We do not enter into hedges to minimize volatility of reported earnings because we do not believe it is justified by the exposure or the cost.

 

Changes in currency exchange rates that would have the largest impact on translating future international operating profit include the euro, British pound, Canadian dollar, and Swiss franc. We estimate that a 10% change in foreign exchange rates would not have materially affected reported operating profit for the year ended December 31, 2002. We believe that this quantitative measure has inherent limitations because, as discussed in the first paragraph of this section, it does not take into account other important economic factors interrelated to such changes, or any changes in customer purchasing patterns or financing and operating strategies.

 

Interest Rate Risk

 

Our exposure to interest rate risk is limited to our unsecured line of credit and our investments in marketable securities. Our line of credit bears interest at either the prevailing prime rate, or the prevailing London Interbank Offered Rate plus 1.5%, at our option. No amounts were outstanding under this line of credit as of December 31, 2002. Our long-term debt instruments carry fixed interest rates. Our investments in marketable securities, which totaled $240.3 million at December 31, 2002, are sensitive to changes in the general level of U.S. interest rates. We estimate that a 10% decline in the interest earned on our investment portfolio would have resulted in an after tax decline in our net income of $0.9 million for the year ended December 31, 2002.

 

The sensitivity analyses presented in the interest rate and foreign exchange discussions above disregard the possibility that rates can move in opposite directions and that gains from one category may or may not be offset by losses from another category and vice versa.

 

Item 8.    Financial Statements and Supplementary Data

 

The financial statements required by this item are included in Part IV, Item 15 of this Annual Report on Form 10-K and are presented beginning on page F-1. The supplementary financial information required by this item is included in Note 17, Supplementary Quarterly Consolidated Financial Data (Unaudited), of the Notes to Consolidated Financial Statements on page F-27.

 

Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

Not applicable.

 

33


Table of Contents

PART III

 

Item 10.    Directors and Executive Officers of the Registrant

 

The information required hereunder is incorporated herein by reference to our Proxy Statement to be filed within 120 days of December 31, 2002 and delivered to stockholders in connection with our Annual Meeting of Stockholders to be held on May 21, 2003.

 

Item 11.    Executive Compensation

 

The information required hereunder is incorporated herein by reference to our Proxy Statement to be filed within 120 days of December 31, 2002 and delivered to stockholders in connection with our Annual Meeting of Stockholders to be held on May 21, 2003.

 

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The information required hereunder is incorporated herein by reference to our Proxy Statement to be filed within 120 days of December 31, 2002 and delivered to stockholders in connection with our Annual Meeting of Stockholders to be held on May 21, 2003.

 

Item 13.    Certain Relationships and Related Transactions

 

The information required hereunder is incorporated herein by reference to our Proxy Statement to be filed within 120 days of December 31, 2002 and delivered to stockholders in connection with our Annual Meeting of Stockholders to be held on May 21, 2003.

 

Item 14.    Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our chief executive officer and our chief financial officer, after evaluating our “disclosure controls and procedures” (as defined in Securities Exchange Act of 1934 (the “Exchange Act”) Rules 13a-14(c) and 15-d-14(c)) as of a date (the “Evaluation Date”) within 90 days before the filing date of this Annual Report on Form 10-K have concluded that as of the Evaluation Date, our disclosure controls and procedures are effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

 

Changes in Internal Controls

 

Subsequent to the Evaluation Date, there were no significant changes in our internal controls or in other factors that could significantly affect our disclosure controls and procedures, nor were there any significant deficiencies or material weaknesses in our internal controls. As a result, no corrective actions were required or undertaken.

 

34


Table of Contents

PART IV

 

Item 15.    Exhibits, Financial Statement Schedules, and Reports on Form 8-K

 

  (a)   The following documents are filed as part of this Annual Report on Form 10-K:

 

(1) Financial Statements.

 

See Index to Financial Statements and Schedules on page F-1.

 

(2) Financial Statement Schedules.

 

See Index to Financial Statements and Schedules on page F-1. All other schedules are omitted as the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements or notes thereto.

 

(3) Exhibits.

 

The following exhibits are filed (or incorporated by reference herein) as part of this Annual Report on Form 10-K:

 

Exhibit Number


  

Description of Exhibit


  2.1

  

Agreement and Plan of Merger dated January 22, 2002, among the Registrant, Magnesium Acquisition Corp. and Micro Robotics Systems, Inc. (incorporated by reference to Exhibit 2.1 of the Registrant’s Registration Statement of Form S-3, File No. 333-86264, filed with the Securities and Exchange Commission on April 15, 2002).

  3.1

  

Restated Articles of Incorporation of the Registrant filed November 19, 1987 (incorporated by reference to exhibit in the Registrant’s 1987 Proxy Statement).

  3.2

  

Certificate of Amendment to Articles of Incorporation of the Registrant, as filed May 30, 2000 (incorporated by reference to Exhibit 3.2 to the Registrant’s Registration Statement on Form S-3, No. 333-40878, filed with the Securities and Exchange Commission on July 6, 2000).

  3.3

  

Certificate of Amendment to Articles of Incorporation of the Registrant, as filed June 26, 2001 (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 10-Q for the quarter ended June 30, 2001).

  3.4

  

Restated Bylaws of the Registrant, as amended to date (incorporated by reference to Exhibit 3.2 of the Registrant’s Annual Report on Form 10-K for the year ended July 31, 1992).

10.1

  

Lease Agreement dated March 27, 1991, as amended, pertaining to premises located in Irvine, California (incorporated by reference to Exhibit 10.1 of the Registrant’s Annual Report on Form 10-K for the year ended July 31, 1992).

10.2

  

First Amendment to Lease, dated January 31, 2002, between the Registrant and IRP Muller Associates, LLC pertaining to premises located in Irvine, California (incorporated by reference to Exhibit 10.2 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2001).

10.3

  

Lease Agreement dated November 1, 2000, between the Registrant and Arden Realty Limited Partnership pertaining to premises located in Santa Ana, California (incorporated by reference to Exhibit 10.2 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2000).

 

35


Table of Contents

Exhibit Number


  

Description of Exhibit


  10.4

  

First Amendment to Lease, dated May 23, 2001, between the Registrant and Arden Realty Limited Partnership pertaining to premises located in Santa Ana, California (incorporated by reference to Exhibit 10.4 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2001).

  10.5*

  

1992 Stock Incentive Plan (incorporated by reference to exhibit in the Registrant’s 1992 Proxy Statement).

  10.6*

  

1999 Stock Incentive Plan (incorporated by reference to Exhibit 10.11 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 1999).

  10.7*

  

Amendment to 1999 Stock Incentive Plan (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form S-3, No. 333-40878, filed with the Securities and Exchange Commission on July 6, 2000).

  10.8*

  

2001 Stock Incentive Plan (incorporated by reference to Appendix B to the Registrant’s Definitive Proxy Statement filed on April 27, 2001).

  10.9*

  

Form of Nonqualified Stock Option Agreement under the 2001 Stock Incentive Plan, as amended.

  10.10*

  

Form of Incentive Stock Option Agreement under the 2001 Stock Incentive Plan.

  10.11*

  

Form of Nonqualified Stock Option Agreement between the Registrant and each of the former optionholders of Micro Robotics Systems, Inc. (incorporated by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form S-8, File No. 333-86268, filed with the Securities and Exchange Commission on April 15, 2002).

  10.12*

  

Employee Stock Purchase Plan, as amended (incorporated by reference to Exhibit 10.10 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2001).

  10.13*

  

Form of Severance Compensation Agreement between the Registrant and certain of its executive officers (incorporated by reference to Exhibit 10.7 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 1993).

  10.14*

  

Severance Compensation Agreement dated as of April 8, 1996, between the Registrant and Robert J. Phillippy, Vice President and General Manager (incorporated by reference to Exhibit 10.2 of the Registrant’s Form 10-Q for the quarter ended September 30, 1996).

  10.15*

  

Severance Compensation Agreement dated as of May 1, 1996, between the Registrant and Robert G. Deuster, President and Chief Executive Officer (incorporated by reference to Exhibit 10.3 of the Registrant’s Form 10-Q for the quarter ended September 30, 1996).

  10.16

  

Form of Indemnification Agreement between the Registrant and each of its directors and officers (incorporated by reference to Exhibit 10.3 of the Registrant’s Form 10-Q for the quarter ended June 30, 2002).

  10.17

  

Note Agreement dated as of May 2, 1996 between the Registrant and The Prudential Insurance Company of America (incorporated by reference to Exhibit 10.1 of the Registrant’s Form 10-Q for the quarter ended March 31, 1996).

 

36


Table of Contents

Exhibit Number


  

Description of Exhibit


  10.18

  

Fifth Modification of Note Agreement dated July 30, 2002, between the Registrant and The Prudential Insurance Company of America (incorporated by reference to Exhibit 10.2 of the Registrant’s Form 10-Q for the quarter ended June 30, 2002).

  10.19

  

Sixth Modification of Note Agreement dated March 20, 2003, between the Registrant and The Prudential Insurance Company of America.

  10.20

  

Business Loan Agreement dated September 25, 2002, by and between the Registrant and Bank of America, N.A. (incorporated by reference to Exhibit 10.3 of the Registrant’s Form 10-Q for the quarter ended September 30, 2002).

  10.21

  

Promissory Note dated September 25, 2002, payable by the Registrant to Bank of America, N.A. (incorporated by reference to Exhibit 10.4 of the Registrant’s Form 10-Q for the quarter ended September 30, 2002).

  10.22

  

Commercial Pledge Agreement dated September 25, 2002, by and between the Registrant and Bank of America, N.A. (incorporated by reference to Exhibit 10.5 of the Registrant’s Form 10-Q for the quarter ended September 30, 2002).

  21.1

  

Subsidiaries of Registrant.

  23.1

  

Consent of Ernst & Young LLP, Independent Auditors.

  23.2

  

Consent of PricewaterhouseCoopers LLP, Independent Auditors.

  99.1

  

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.

  99.2

  

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.


*   This exhibit is identified as a management contract or compensatory plan or arrangement pursuant to Item 15(a)(3) of Form 10-K.

 

  (b)   Reports on Form 8-K.

 

On October 18, 2002, we filed a Current Report on Form 8-K, Item 9, disclosing revised unaudited financial and business information for the six quarters through June 30, 2002. Such information was revised to reflect the impact of the reorganization of our operating segments, the change in the manner in which we measure segment operating income, and the discontinuation of our Plymouth, Minnesota operations.

 

37


Table of Contents

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 26, 2003.

 

NEWPORT CORPORATION

By:

 

/s/    ROBERT G. DEUSTER        


   

Robert G. Deuster
Chairman of the Board, President
and Chief Executive Officer

 

POWER OF ATTORNEY

 

The undersigned directors and officers of Newport Corporation constitute and appoint Robert G. Deuster and Charles F. Cargile, or either of them, as their true and lawful attorney and agent with power of substitution, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorney and agent may deem necessary or advisable to enable said corporation to comply with the Securities Exchange Act of 1934, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with this Annual Report on Form 10-K, including specifically but without limitation, power and authority to sign for us or any of us in our names in the capacities indicated below, any and all amendments (including post-effective amendments) hereto; and we do hereby ratify and confirm all that said attorney and agent shall do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

SIGNATURE


  

TITLE


 

DATE


/s/    ROBERT G. DEUSTER        


Robert G. Deuster

  

Chairman of the Board, President and
Chief Executive Officer (Principal Executive Officer)

 

March 26, 2003

/s/    CHARLES F. CARGILE        


Charles F. Cargile

  

Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

 

March 26, 2003

/s/    R. JACK APLIN        


R. Jack Aplin

  

Director

 

March 26, 2003

/s/    ROBERT L. GUYETT        


Robert L. Guyett

  

Director

 

March 26, 2003

/s/    C. KUMAR N. PATEL        


C. Kumar N. Patel

  

Director

 

March 26, 2003

/s/    KENNETH F. POTASHNER        


Kenneth F. Potashner

  

Director

 

March 26, 2003

/s/    RICHARD E. SCHMIDT        


Richard E. Schmidt

  

Director

 

March 26, 2003

 

38


Table of Contents

CERTIFICATIONS

 

I, Robert G. Deuster, Chairman, President and Chief Executive Officer of Newport Corporation, certify that:

 

  1.   I have reviewed this annual report on Form 10-K of Newport Corporation;

 

  2.   Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

 

  3.   Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

 

  4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-14 and 15d-14 of the Exchange Act) for the registrant and have:

 

  a)   Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

 

  b)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the “Evaluation Date”); and

 

  c)   Presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

  5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  a)   All significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

  b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

  6.   The registrant’s other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

Date:  March 26, 2003

 

/s/    ROBERT G. DEUSTER        


Robert G. Deuster

Chairman, President, and Chief Executive Officer

(Principal Executive Officer)

 

39


Table of Contents

I, Charles F. Cargile, Vice President and Chief Financial Officer of Newport Corporation, certify that:

 

  1.   I have reviewed this annual report on Form 10-K of Newport Corporation;

 

  2.   Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

 

  3.   Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

 

  4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-14 and 15d-14 of the Exchange Act) for the registrant and have:

 

  a)   Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

 

  b)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the “Evaluation Date”); and

 

  c)   Presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

  5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  a)   All significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

  b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

  6.   The registrant’s other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

Date:  March 26, 2003

/s/    CHARLES F. CARGILE        


Charles F. Cargile

Vice President and Chief Financial Officer

(Principal Financial Officer)

 

 

40


Table of Contents

INDEX TO FINANCIAL STATEMENTS AND SCHEDULES

 

    

Page


Report of Ernst & Young LLP, Independent Auditors

  

F-2

Report of PricewaterhouseCoopers LLP, Independent Auditors

  

F-3

Consolidated statements of operations for the years ended December 31, 2002, 2001 and 2000

  

F-4

Consolidated balance sheets at December 31, 2002 and 2001

  

F-5

Consolidated statements of cash flows for the years ended December 31, 2002, 2001 and 2000

  

F-6

Consolidated statements of comprehensive income (loss) and stockholders’ equity for the years ended December 31, 2002, 2001 and 2000

  

F-7

Notes to Consolidated Financial Statements

  

F-8

Financial Statement Schedule—Schedule II—Consolidated valuation accounts

  

F-28

 

F-1


Table of Contents

Report of Ernst & Young LLP, Independent Auditors

 

The Board of Directors and Stockholders

of Newport Corporation

 

We have audited the accompanying consolidated balance sheets of Newport Corporation as of December 31, 2002 and 2001, and the related consolidated statements of operations, comprehensive income (loss) and stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2002. Our audits also included the financial statement schedule listed in Item 15(a). These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits. We did not audit the financial statements of Kensington Laboratories, Inc., a wholly owned subsidiary, for the year ended December 31, 2000. Those financial statements, reflecting total revenues constituting 11% of consolidated net sales, were audited by other auditors whose report has been furnished to us, and our opinion, insofar as it relates to data included for Kensington Laboratories, Inc., is based solely on the report of the other auditors.

 

We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits and the report of other auditors provide a reasonable basis for our opinion.

 

In our opinion, based on our audits and the report of other auditors, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Newport Corporation at December 31, 2002 and 2001, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2002, in conformity with accounting principles generally accepted in the United States. Also, in our opinion, based on our audits and the report of other auditors, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.

 

As described in Note 1 of the Notes to Consolidated Financial Statements, effective January 1, 2002, the Company adopted Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets.

 

/s/    ERNST & YOUNG LLP

 

Orange County, California

January 24, 2003

 

F-2


Table of Contents

Report of PricewaterhouseCoopers LLP, Independent Auditors

 

To the Board of Directors and Stockholders

of Newport Corporation

 

In our opinion, the statement of operations and retained earnings and of cash flows of Kensington Laboratories, Inc. (not presented separately herein) present fairly, in all material respects, the results of its operations and its cash flows for the year ended December 31, 2000 in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of Kensington Laboratories, Inc.’s management; our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit of these statements in accordance with auditing standards generally accepted in the United States of America, which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. We have not audited the financial statements of Kensington Laboratories, Inc. for any period subsequent to December 31, 2000.

 

/s/    PRICEWATERHOUSECOOPERS LLP

 

San Jose, California

February 2, 2001

 

F-3


Table of Contents

NEWPORT CORPORATION

 

Consolidated Statements of Operations

 

(In thousands except per share amounts)

  

Years Ended December 31,


 
    

2002


    

2001


    

2000


 

Net sales

  

$

163,994

 

  

$

289,963

 

  

$

262,597

 

Cost of sales

  

 

138,183

 

  

 

192,698

 

  

 

138,539

 

    


  


  


Gross profit

  

 

25,811

 

  

 

97,265

 

  

 

124,058

 

Selling, general and administrative expense

  

 

50,222

 

  

 

57,311

 

  

 

51,453

 

Research and development expense

  

 

24,383

 

  

 

26,073

 

  

 

21,682

 

Restructuring and impairment charges

  

 

11,883

 

  

 

11,584

 

  

 

—  

 

Acquisition and other non-recurring charges

  

 

—  

 

  

 

10,683

 

  

 

—  

 

    


  


  


Operating income (loss)

  

 

(60,677

)

  

 

(8,386

)

  

 

50,923

 

Interest and other income, net

  

 

10,269

 

  

 

13,786

 

  

 

6,041

 

Asset write-down

  

 

(6,490

)

  

 

—  

 

  

 

—  

 

    


  


  


Income (loss) from continuing operations before income taxes

  

 

(56,898

)

  

 

5,400

 

  

 

56,964

 

Income tax provision

  

 

14,011

 

  

 

1,929

 

  

 

12,936

 

    


  


  


Income (loss) from continuing operations

  

 

(70,909

)

  

 

3,471

 

  

 

44,028

 

Loss from discontinued operations, net of income tax benefit of zero, $5,018 and $791 in 2002, 2001 and 2000, respectively

  

 

(15,209

)

  

 

(9,743

)

  

 

(2,055

)

Cumulative effect of a change in accounting principle

  

 

(14,500

)

  

 

—  

 

  

 

—  

 

    


  


  


Net income (loss)

  

$

(100,618

)

  

$

(6,272

)

  

$

41,973

 

    


  


  


Earnings (loss) per share, basic:

                          

Income (loss) from continuing operations

  

$

(1.87

)

  

$

0.10

 

  

$

1.32

 

Loss from discontinued operations, net of income taxes

  

$

(0.40

)

  

$

(0.27

)

  

$

(0.07

)

Cumulative effect of a change in accounting principle

  

$

(0.38

)

  

 

—  

 

  

 

—  

 

    


  


  


Net income (loss)

  

$

(2.65

)

  

$

(0.17

)

  

$

1.25

 

    


  


  


Earnings (loss) per share, diluted:

                          

Income (loss) from continuing operations

  

$

(1.87

)

  

$

0.09

 

  

$

1.23

 

Loss from discontinued operations, net of income taxes

  

$

(0.40

)

  

$

(0.26

)

  

$

(0.06

)

Cumulative effect of a change in accounting principle

  

$

(0.38

)

  

 

—  

 

  

 

—  

 

    


  


  


Net income (loss)

  

$

(2.65

)

  

$

(0.17

)

  

$

1.17

 

    


  


  


Number of shares used to calculate earnings (loss) per share

                          

Basic

  

 

37,970

 

  

 

36,405

 

  

 

33,464

 

Diluted

  

 

37,970

 

  

 

37,830

 

  

 

35,835

 

Dividends per share

  

 

—  

 

  

$

0.01

 

  

$

0.02

 

 

See accompanying notes.

 

F-4


Table of Contents

NEWPORT CORPORATION

 

Consolidated Balance Sheets

 

(In thousands except share and per share data)

  

December 31,


 
    

2002


    

2001


 

ASSETS

                 

Current assets:

                 

Cash and cash equivalents

  

$

44,059

 

  

$

7,107

 

Marketable securities

  

 

240,254

 

  

 

274,494

 

Customer receivables, net

  

 

18,534

 

  

 

29,663

 

Inventories

  

 

54,964

 

  

 

82,618

 

Deferred tax assets

  

 

—  

 

  

 

11,091

 

Assets of discontinued operations

  

 

3,840

 

  

 

20,118

 

Other current assets

  

 

7,995

 

  

 

15,030

 

    


  


Total current assets

  

 

369,646

 

  

 

440,121

 

Property, plant and equipment, net

  

 

35,774

 

  

 

40,604

 

Goodwill, net

  

 

57,529

 

  

 

14,531

 

Deferred tax assets

  

 

15,570

 

  

 

22,240

 

Investments and other assets

  

 

7,819

 

  

 

6,277

 

Assets of discontinued operations

  

 

—  

 

  

 

20,104

 

    


  


    

$

486,338

 

  

$

543,877

 

    


  


LIABILITIES AND STOCKHOLDERS’ EQUITY

                 

Current liabilities:

                 

Accounts payable

  

$

6,213

 

  

$

10,513

 

Accrued payroll and related expenses

  

 

9,900

 

  

 

10,705

 

Current portion of long-term debt

  

 

2,214

 

  

 

6,189

 

Accrued restructuring costs

  

 

5,974

 

  

 

5,297

 

Deferred revenue

  

 

3,261

 

  

 

823

 

Liabilities of discontinued operations

  

 

161

 

  

 

7,715

 

Accrued warranty obligations

  

 

2,047

 

  

 

1,664

 

Other current liabilities

  

 

8,547

 

  

 

7,897

 

    


  


Total current liabilities

  

 

38,317

 

  

 

50,803

 

Long-term debt

  

 

1,230

 

  

 

3,409

 

Other liabilities

  

 

274

 

  

 

658

 

Commitments and contingencies

                 

Stockholders’ equity:

                 

Common stock, $0.1167 stated value, 200,000,000 shares authorized; 38,560,000 issued and outstanding at December 31, 2002; 36,693,000 shares issued and outstanding at December 31, 2001

  

 

4,500

 

  

 

4,282

 

Capital in excess of stated value

  

 

439,466

 

  

 

389,526

 

Unamortized deferred compensation

  

 

(215

)

  

 

(293

)

Accumulated other comprehensive loss

  

 

(1,241

)

  

 

(9,133

)

Retained earnings

  

 

4,007

 

  

 

104,625

 

    


  


Total stockholders’ equity

  

 

446,517

 

  

 

489,007

 

    


  


    

$

486,338

 

  

$

543,877

 

    


  


 

See accompanying notes.

 

F-5


Table of Contents

NEWPORT CORPORATION

 

Consolidated Statements of Cash Flows

 

(In thousands)

  

Years Ended December 31,


 
    

2002


    

2001


    

2000


 

Operating activities:

                          

Net income (loss)

  

$

(100,618

)

  

$

(6,272

)

  

$

41,973

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

                          

Depreciation and non-goodwill amortization

  

 

11,119

 

  

 

12,230

 

  

 

11,349

 

Goodwill amortization

  

 

—  

 

  

 

2,471

 

  

 

1,083

 

Provision for losses on inventory

  

 

31,981

 

  

 

26,424

 

  

 

3,682

 

Impairment of goodwill

  

 

14,500

 

  

 

—  

 

  

 

—  

 

Provision for restructuring related charges

  

 

11,883

 

  

 

11,584

 

  

 

—  

 

Deferred income taxes, net

  

 

18,532

 

  

 

(16,286

)

  

 

(13,726

)

Loss on disposal of business

  

 

6,843

 

  

 

—  

 

  

 

—  

 

Asset write-down

  

 

6,490

 

  

 

—  

 

  

 

—  

 

Tax benefit from stock option exercises

  

 

—  

 

  

 

7,708

 

  

 

16,995

 

Other non-cash items, net

  

 

1,165

 

  

 

(500

)

  

 

154

 

Changes in operating assets and liabilities, net of effects of acquisitions:

                          

Customer receivables

  

 

14,819

 

  

 

27,961

 

  

 

(33,164

)

Income tax receivable

  

 

—  

 

  

 

7,793

 

  

 

(4,108

)

Inventories

  

 

699

 

  

 

(41,423

)

  

 

(40,290

)

Other current assets

  

 

3,261

 

  

 

(2,054

)

  

 

(3,965

)

Other assets

  

 

83

 

  

 

(875

)

  

 

(820

)

Accounts payable and accrued expenses

  

 

(13,648

)

  

 

(11,135

)

  

 

25,164

 

Deferred revenue

  

 

(195

)

  

 

(3,612

)

  

 

(364

)

Other, net

  

 

(372

)

  

 

601

 

  

 

804

 

    


  


  


Net cash provided by operating activities

  

 

6,542

 

  

 

14,615

 

  

 

4,767

 

    


  


  


Investing activities:

                          

Purchases of property, plant and equipment

  

 

(6,681

)

  

 

(19,605

)

  

 

(18,663

)

Proceeds from sale of business and property, plant and equipment

  

 

9,872

 

  

 

—  

 

  

 

503

 

Acquisition of businesses, net of cash acquired

  

 

(6,437

)

  

 

(12,984

)

  

 

(50

)

Purchases of marketable securities

  

 

(493,205

)

  

 

(746,174

)

  

 

(314,451

)

Sales of marketable securities

  

 

529,799

 

  

 

762,943

 

  

 

25,571

 

Purchases of intellectual property

  

 

(2,025

)

  

 

—  

 

  

 

(1,157

)

Payments for equity investments

  

 

—  

 

  

 

(1,250

)

  

 

(1,510

)

Proceeds from sale of equity investments

  

 

—  

 

  

 

—  

 

  

 

1,430

 

    


  


  


Net cash provided by (used in) investing activities

  

 

31,323

 

  

 

(17,070

)

  

 

(308,327

)

    


  


  


Financing activities:

                          

Payments on long-term borrowings

  

 

(6,536

)

  

 

(7,502

)

  

 

(11,453

)

Issuance of common stock under employee plans

  

 

4,961

 

  

 

5,242

 

  

 

7,240

 

Payments on credit line

  

 

—  

 

  

 

—  

 

  

 

(10,000

)

Cash dividends paid

  

 

—  

 

  

 

(690

)

  

 

(555

)

Other distributions to shareholders

  

 

—  

 

  

 

(3,821

)

  

 

(4,013

)

Proceeds from sale of common stock, net

  

 

—  

 

  

 

—  

 

  

 

329,851

 

    


  


  


Net cash provided by (used in) financing activities

  

 

(1,575

)

  

 

(6,771

)

  

 

311,070

 

Effect of foreign exchange rate changes on cash

  

 

662

 

  

 

(528

)

  

 

110

 

    


  


  


Increase (decrease) in cash and cash equivalents

  

 

36,952

 

  

 

(9,754

)

  

 

7,620

 

Cash and cash equivalents at beginning of year

  

 

7,107

 

  

 

16,861

 

  

 

9,241

 

    


  


  


Cash and cash equivalents at end of year

  

$

44,059

 

  

$

7,107

 

  

$

16,861

 

    


  


  


 

See accompanying notes.

 

F-6


Table of Contents

NEWPORT CORPORATION

 

Consolidated Statements of Comprehensive Income (Loss) and Stockholders’ Equity

 

(In thousands)

  

Common Stock


  

Capital in excess of

stated

value


    

Unamortized deferred compensation


      

Accumulated

other comprehensive loss


    

Retained earnings


    

Total


 
    

Shares


  

Amount


                  

December 31, 1999

  

31,413

  

$

3,666

  

$

8,960

    

$

(417

)

    

$

(6,635

)

  

$

77,672

 

  

$

83,246

 

Net income

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

—  

 

  

 

41,973

 

  

 

41,973

 

Foreign currency translation loss

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

(1,501

)

  

 

—  

 

  

 

(1,501

)

Unrealized gain on marketable securities

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

901

 

  

 

—  

 

  

 

901

 

                                                      


Comprehensive income

                                                    

 

41,373

 

Issuance of common stock through secondary offering

  

3,100

  

 

362

  

 

329,489

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

329,851

 

Issuance of common stock under employee plans

  

1,503

  

 

175

  

 

7,065

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

7,240

 

Tax benefits from stock option exercises

  

—  

  

 

—  

  

 

16,995

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

16,995

 

Grants of restricted common stock, net

  

60

  

 

7

  

 

2,400

    

 

(2,407

)

    

 

—  

 

  

 

—  

 

  

 

—  

 

Amortization of deferred compensation

  

—  

  

 

—  

  

 

—  

    

 

1,828

 

    

 

—  

 

  

 

—  

 

  

 

1,828

 

Other

  

120

  

 

14

  

 

9,986

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

10,000

 

Dividends

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

—  

 

  

 

(609

)

  

 

(609

)

Distribution of S-Corp earnings

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

—  

 

  

 

(3,959

)

  

 

(3,959

)

    
  

  

    


    


  


  


December 31, 2000

  

36,196

  

$

4,224

  

$

374,895

    

$

(996

)

    

$

(7,235

)

  

$

115,077

 

  

$

485,965

 

Net loss

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

—  

 

  

 

(6,272

)

  

 

(6,272

)

Foreign currency translation loss

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

(3,379

)

  

 

—  

 

  

 

(3,379

)

Unrealized gain on marketable securities

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

1,481

 

  

 

—  

 

  

 

1,481

 

                                                      


Comprehensive loss

                                                    

 

(8,170

)

Issuance of common stock under employee plans

  

493

  

 

58

  

 

5,184

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

5,242

 

Tax benefits from stock option exercises

  

—  

  

 

—  

  

 

7,708

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

7,708

 

Grants of restricted common stock, net

  

4

  

 

—  

  

 

304

    

 

(304

)

    

 

—  

 

  

 

—  

 

  

 

—  

 

Amortization of deferred compensation

  

—  

  

 

—  

  

 

—  

    

 

1,007

 

    

 

—  

 

  

 

—  

 

  

 

1,007

 

Dividends

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

—  

 

  

 

(359

)

  

 

(359

)

Distribution of S-Corp earnings

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

—  

 

  

 

(3,821

)

  

 

(3,821

)

Other

  

—  

  

 

—  

  

 

1,435

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

1,435

 

    
  

  

    


    


  


  


December 31, 2001

  

36,693

  

$

4,282

  

$

389,526

    

$

(293

)

    

$

(9,133

)

  

$

104,625

 

  

$

489,007

 

Net loss

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

—  

 

  

 

(100,618

)

  

 

(100,618

)

Foreign currency translation gain

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

6,614

 

  

 

—  

 

  

 

6,614

 

Unrealized gain on marketable securities

  

—  

  

 

—  

  

 

—  

    

 

—  

 

    

 

1,278

 

  

 

—  

 

  

 

1,278

 

                                                      


Comprehensive loss

                                                    

 

(92,726

)

Acquisition of MRSI

  

997

  

 

116

  

 

45,081

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

45,197

 

Issuance of common stock under employee plans

  

870

  

 

102

  

 

4,859

    

 

—  

 

    

 

—  

 

  

 

—  

 

  

 

4,961

 

Amortization of deferred compensation

  

—  

  

 

—  

  

 

—  

    

 

78

 

    

 

—  

 

  

 

—  

 

  

 

78

 

    
  

  

    


    


  


  


December 31, 2002

  

38,560

  

$

4,500

  

$

439,466

    

$

(215

)

    

$

(1,241

)

  

$

4,007

 

  

$

446,517

 

    
  

  

    


    


  


  


 

 

See accompanying notes.

 

F-7


Table of Contents

NOTE 1    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization.    Newport Corporation (Newport or the Company) is a global supplier of advanced technology products and systems to a wide range of industries, including semiconductor manufacturing and advanced packaging equipment, aerospace and defense, life and health sciences, scientific research and fiber optic communications equipment. The Company provides components and integrated subsystems to manufacturers of semiconductor front-end processing equipment; automated systems for semiconductor back-end packaging applications to integrated device manufacturers; automated assembly and test systems to manufacturers of fiber optic components; and a broad array of high-precision components and instruments to commercial, academic and government customers worldwide. Newport’s products leverage its expertise in precision robotics and automation, high-precision positioning systems, vibration isolation technology, precision optics and optomechanics to enhance the capabilities and productivity of its customers’ manufacturing, engineering and research applications. Newport is part of the Standard & Poor’s Midcap 400 Index and the Russell 2000 Index.

 

Consolidation and Presentation.    The accompanying financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany transactions and balances have been eliminated. Certain reclassifications have been made to prior year amounts to conform to the current year presentation.

 

Use of Estimates.    The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant estimates made in preparing the consolidated financial statements include the allowance for doubtful accounts, inventory reserves, warranty obligations, restructuring reserves, asset impairment valuations and income tax valuations.

 

Revenue Recognition.    A sale is recorded after all significant obligations have been met, collectibility is probable and title has passed, which typically occurs upon shipment or completion of services. Customers generally have 30 days from the original invoice date (generally 60 days for international customers) to return a standard catalog product purchase for exchange or credit. The catalog product must be returned in its original condition and meet certain other criteria. Product returns of catalog items have historically been insignificant and are charged against revenue in the period returned. Custom, option-configured and certain other products as defined in the terms and conditions of sale cannot be returned.

 

Shipping and Handling Costs.    Included in selling, general and administrative expense is $1.8 million, $3.3 million and $1.9 million of shipping costs for 2002, 2001 and 2000, respectively.

 

Warranty.    Unless otherwise stated, the Company provides a one-year warranty from the original invoice date on all product material and workmanship. Products sold to certain original equipment manufacturer customers sometimes carry longer warranties. Defective products will be either repaired or replaced, generally at the Company’s option, upon meeting certain criteria. The Company accrues a provision for the estimated costs that may be incurred for product warranties relating to a product as a component of cost of sales at the time revenue for that product is recognized. The activity in accrued warranty obligations is as follows:

 

(In thousands)

  

Years Ended December 31,


 
    

2002


    

2001


    

2000


 

Balance at beginning of year

  

$

1,664

 

  

$

467

 

  

$

403

 

Additions charged to cost of sales

  

 

3,913

 

  

 

5,261

 

  

 

1,965

 

Warranty claims

  

 

(3,530

)

  

 

(4,064

)

  

 

(1,901

)

    


  


  


Balance at end of year

  

$

2,047

 

  

$

1,664

 

  

$

467

 

    


  


  


 

F-8


Table of Contents

 

Income Taxes.    The Company recognizes the amount of current and deferred taxes payable or refundable at the date of the financial statements as a result of all events that have been recognized in the financial statements and as measured by the provisions of enacted laws.

 

Depreciation and Amortization.    Property, plant and equipment is depreciated on a straight line basis over estimated useful lives of the assets ranging from three to twenty years. Leasehold improvements are generally amortized over the related lease term.

 

Advertising.    The Company expenses the costs of advertising as incurred, except for direct-response advertising, which is capitalized and amortized over its expected period of future benefits. Direct-response advertising consists of product catalogs. The Company uses its principal catalog, The Newport Resource, as its primary marketing tool for the scientific market. The catalog provides detailed product information as well as extensive technical and applications data. The catalog is published in English, French, German and Japanese and is mailed worldwide to approximately 40,000 existing and potential customers. Included in other current assets is $0.2 million of capitalized catalog costs at December 31, 2002 and 2001. Advertising costs were $1.1 million, $2.1 million, and $1.6 million for 2002, 2001 and 2000, respectively.

 

Earnings (Loss) per Share.    Basic earnings per share is computed using the weighted average number of shares of common stock outstanding during the periods, excluding restricted stock. Diluted earnings per share is computed using the weighted average number of shares of common stock outstanding during the periods, excluding restricted stock, and the dilutive effects of common stock equivalents (restricted stock and stock options) outstanding during the periods, determined using the treasury stock method. Diluted loss per share excludes the antidilutive effects of common stock equivalents outstanding during the periods (Note 14).

 

In May 2000, the Company affected a three-for-one stock split of its shares of common stock. Share and per share information for all periods presented have been adjusted to reflect the stock split.

 

Cash, Cash Equivalents and Marketable Securities.    Cash and cash equivalents consist primarily of interest bearing investments with original maturities of 90 days or less at the date of purchase. The Company considers all liquid interest-earning investments with a maturity of more than three months at the date of purchase to be marketable securities. Marketable securities generally have a modified duration between three months and five years from the purchase date. All marketable securities are classified as available for sale and are recorded at market value using the specific identification method; unrealized gains and losses are reflected in other comprehensive income (loss). Cash, cash equivalents and marketable securities consist of the following:

 

(In thousands)

  

December 31,


    

2002


  

2001


Marketable securities:

             

Commercial paper

  

$

501

  

$

9,471

U.S. government and agency securities

  

 

62,927

  

 

41,894

Corporate notes and bonds

  

 

82,053

  

 

79,422

Asset backed securities

  

 

31,777

  

 

18,329

Municipal notes and bonds

  

 

53,426

  

 

116,413

Certificates of deposit

  

 

9,570

  

 

8,965

    

  

    

 

240,254

  

 

274,494

Cash and cash equivalents

  

 

44,059

  

 

7,107

    

  

    

$

284,313

  

$

281,601

    

  

 

Maturity distribution of the marketable securities at December 31, 2002 is as follows:

 

(In thousands)

    

0 – 1 Year

  

$

65,523

1 – 2 Years

  

 

69,246

2 – 3 Years

  

 

63,545

3 – 5 Years

  

 

41,940

    

    

$

240,254

    

 

F-9


Table of Contents

 

Fair Values of Financial Instruments.    Fair values of cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings and the current portion of long-term debt approximate the carrying value because of the short period of time to maturity. The fair value of long-term debt approximates its carrying value because their rates of interest approximate current market rates. The carrying amounts of the foreign exchange contracts, if any, equal fair value and are adjusted each balance sheet date for changes in exchange rates.

 

Goodwill.    Goodwill represents the excess of the purchase price over the fair value of the net assets of acquired entities.

 

On January 1, 2002, the Company adopted Financial Accounting Standards Board (FASB) Statement No. 142, Goodwill and Other Intangible Assets (Statement 142). Under Statement 142, goodwill is no longer amortized but is subject to impairment tests based upon a comparison of the fair value of each of the Company’s reporting units, as defined, and the carrying value of the reporting units’ net assets, including goodwill. Pursuant to Statement 142, upon adoption the Company tested its goodwill for impairment and recorded an impairment charge, based upon an independent valuation, of $14.5 million as the cumulative effect of a change in accounting principle as of January 1, 2002. Statement 142 requires a review for impairment at least annually or when circumstances exist that would indicate an impairment of such goodwill. The Company performs the annual impairment review as of October 1 of each year. The 2002 annual review resulted in no additional impairment of the carrying value of goodwill. At December 31, 2002, the Company had goodwill of approximately $57.5 million. Adjusted net income and the related earnings per share impact of the adoption of Statement 142 is as follows:

 

(In thousands except per share amounts)

  

Years Ended December 31,


 
    

2002


    

2001


    

2000


 

Reported income (loss) from continuing operations

  

$

(70,909

)

  

$

3,471

 

  

$

44,028

 

Add back goodwill amortization

  

 

—  

 

  

 

2,471

 

  

 

1,083

 

    


  


  


Adjusted net income (loss) from continuing operations

  

 

(70,909

)

  

 

5,942

 

  

 

45,111

 

Loss from discontinued operations, net of income taxes

  

 

(15,209

)

  

 

(9,743

)

  

 

(2,055

)

Cumulative effect of a change in accounting principle

  

 

(14,500

)

  

 

—  

 

  

 

—  

 

    


  


  


Adjusted net income (loss)

  

$

(100,618

)

  

$

(3,801

)

  

$

43,056

 

    


  


  


Basic earnings (loss) per share:

                          

Reported income (loss) from continuing operations

  

$

(1.87

)

  

$

0.10

 

  

$

1.32

 

Add back goodwill amortization

  

 

—  

 

  

$

0.07

 

  

$

0.03

 

    


  


  


Adjusted net income (loss) from continuing operations

  

$

(1.87

)

  

$

0.17

 

  

$

1.35

 

Loss from discontinued operations, net of income taxes

  

$

(0.40

)

  

$

(0.27

)

  

$

(0.07

)

Cumulative effect of change in accounting principle

  

$

(0.38

)

  

 

—  

 

  

 

—  

 

    


  


  


Adjusted net income (loss)

  

$

(2.65

)

  

$

(0.10

)

  

$

1.28

 

    


  


  


Diluted earnings (loss) per share:

                          

Reported income (loss) from continuing operations

  

$

(1.87

)

  

$

0.09

 

  

$

1.23

 

Add back goodwill amortization

  

 

—  

 

  

$

0.07

 

  

$

0.03

 

    


  


  


Adjusted net income (loss) from continuing operations

  

$

(1.87

)

  

$

0.16

 

  

$

1.26

 

Loss from discontinued operations, net of income taxes

  

$

(0.40

)

  

$

(0.26

)

  

$

(0.06

)

Cumulative effect of change in accounting principle

  

$

(0.38

)

  

 

—  

 

  

 

—  

 

    


  


  


Adjusted net income (loss)

  

$

(2.65

)

  

$

(0.10

)

  

$

1.20

 

    


  


  


 

Foreign Currency.    Balance sheet accounts denominated in foreign currency are translated at exchange rates as of the date of the balance sheet and income statement accounts are translated at average exchange rates

 

F-10


Table of Contents

for the period. Translation gains and losses are accumulated as a separate component of Comprehensive Income (Loss). The Company has adopted local currencies as the functional currencies for its subsidiaries because their principal economic activities are most closely tied to the respective local currencies.

 

Stock-Based Compensation.    The Company accounts for stock-based employee compensation arrangements in accordance with Accounting Principles Board Opinion No. 25, Accounting for Stock-Issued to Employees (APB No. 25) and related interpretations, and complies with the disclosure provisions of FASB Statement No. 123, Accounting for Stock-Based Compensation (Statement 123). Under APB No. 25, compensation cost is recognized based on the difference, if any, on the date of the grant between the fair value of the Company’s stock and the amount the employee must pay to acquire the stock.

 

In December 2002, the FASB issued Statement No. 148, Accounting for Stock-Based Compensation—Transition and Disclosure, (Statement 148) providing alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, Statement 148 amends the disclosure requirements to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. The Company does not currently plan to change its stock-based employee compensation accounting to the fair value method. The accompanying financial statements reflect all of the disclosures required by Statement 148.

 

Comprehensive Income (Loss).    The accumulated other comprehensive income (loss) presented in the balance sheet consists of the following:

 

(In thousands)

  

December 31,


 
    

2002


    

2001


 

Cumulative foreign currency translation losses

  

$

(4,901

)

  

$

(11,515

)

Unrealized gains on marketable securities

  

 

3,660

 

  

 

2,382

 

    


  


    

$

(1,241

)

  

$

(9,133

)

    


  


 

Derivative Instruments.    The Company recognizes all derivative financial instruments in the consolidated financial statements at fair value regardless of the purpose or intent for holding the instrument. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. The Company does not engage in currency speculation, however, the Company uses forward exchange contracts to mitigate the risks associated with certain foreign currency transactions entered into in the ordinary course of business, primarily foreign currency denominated receivables. Such contracts do not qualify for hedge accounting and accordingly, changes in fair values are reported in the statement of operations. The forward exchange contracts generally require the Company to exchange U.S. dollars for foreign currencies at maturity, at rates agreed to at the inception of the contracts. If the counterparties to the exchange contracts (AA or A+ rated banks) do not fulfill their obligations to deliver the contracted currencies, the Company could be at risk for any currency related fluctuations. Transaction gains and losses are included in the statement of operations.

 

Foreign exchange contracts totaled $0.4 million and $6.3 million at December 31, 2002 and 2001, respectively. At December 31, 2002, all contracts outstanding matured by January 29, 2003. In addition, none of the outstanding contracts at December 31, 2002 or 2001 qualified for hedge accounting, and the unrealized losses on the outstanding contracts were not material at December 31, 2002 or 2001.

 

Recent Accounting Pronouncements.    On January 1, 2002, the Company adopted FASB Statement No. 141, Business Combinations (Statement 141). Statement 141 eliminates the pooling of interests method of accounting for business combinations and changed the criteria to recognize intangible assets apart from goodwill.

 

F-11


Table of Contents

The Company accounted for the acquisition of Micro Robotics Systems, Inc. (MRSI) in accordance with the provisions of Statement 141.

 

On January 1, 2002, the Company adopted FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (Statement 144). Under Statement 144, long-lived assets, other than goodwill, are evaluated for impairment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. In addition, assets held for sale are included in discontinued operations if the operations and cash flows will be or have been eliminated from the ongoing operations of the entity and the entity will not have any significant continuing involvement in the operations of the component. The discontinuances of the Industrial Metrology Systems Division and the Plymouth, Minnesota facility have been accounted for as discontinued operations under the provisions of Statement 144.

 

In July 2002, the FASB issued Statement No. 146, Accounting for Costs Associated with Exit or Disposal Activities (Statement 146). Statement 146 addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring) (EITF 94-3). Statement 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred. Statement 146 is effective for exit or disposal activities that are initiated after December 31, 2002. Because the Company’s cost reduction and other initiatives occurred prior to December 31, 2002, they have been accounted for under EITF 94-3, and the associated cost has been recognized as of the date of the Board of Directors’ approval of management’s cost reduction plan. If any restructuring activities are undertaken in future years, they will be accounted for under Statement 146.

 

In November 2002, the FASB issued Interpretation No. 45, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others (FIN 45), effective prospectively for guarantees issued or modified after December 31, 2002. The disclosure requirements of FIN 45 are effective for periods ending after December 15, 2002. Under FIN 45, a guarantor is required to recognize, at the inception of certain guarantees, a fair value liability for the obligations it has undertaken in issuing the guarantee, including its ongoing obligation to stand ready to perform over the term of the guarantee in the event that the specified triggering events or conditions occur. FIN 45 clarifies that a guarantor is required to disclose (a) the nature of the guarantee, including the term and circumstances giving rise to the guarantee; (b) the maximum potential amount of future payments under the guarantee; (c) the carrying amount of the liability, if any, for the guarantor’s obligation under the guarantee; and (d) the nature and extent of any recourse or collateral provisions. All guarantees subject to the disclosure provisions of FIN 45, such as product warranties, have been disclosed in the accompanying notes to the consolidated financial statements. The Company does not have any other outstanding guarantees at December 31, 2002 required to be disclosed or recorded as obligations upon adoption of FIN 45.

 

NOTE 2    RESTRUCTURING AND IMPAIRMENT CHARGES

 

2002 Restructuring Plan

 

In August 2002, in response to the continued protracted downturn in the fiber optic communications market and the uncertainty with respect to the pace of recovery in the semiconductor equipment market, the Board of Directors approved management’s cost reduction plan to bring the Company’s operating costs in line with its business outlook at that time.

 

Facility Consolidations

 

As part of this cost reduction plan, the Company closed its Santa Ana, California fiber optics facility and consolidated those operations into its Irvine, California facility. In addition, the Company completed the closure of its San Luis Obispo, California facility and the consolidation of its former Design Technology facility in Billerica, Massachusetts into its MRSI facility, in North Billerica, Massachusetts. Restructuring and impairment

 

F-12


Table of Contents

charges for the year ended December 31, 2002 include $9.2 million for these facility consolidations. In addition, selling, general and administrative expenses for 2002 included $1.5 million of costs related to the closing of these facilities and the completion of the consolidation of its Garden Grove, California facility into its Irvine, California facility.

 

Employee Severance

 

The cost reduction plan included a workforce reduction of approximately 300 employees, of which 187 had been terminated as of December 31, 2002. Approximately one-half of the workforce reduction results from combining the Company’s automation businesses into the new Advanced Packaging and Automation Systems (APAS) division and reducing the scope of the Company’s investment in the fiber optic communications market. Approximately one-quarter of the reduction results from the divestiture of the Company’s discontinued operations, and the remaining reductions result from further streamlining of the Company’s operations. Restructuring and impairment charges for the year ended December 31, 2002 include $3.1 million for employee severance and related termination costs.

 

Inventory Reserves

 

As part of the cost reduction plan, the Company rationalized certain legacy products and discontinued certain product development initiatives. In addition, due to the reduced sales forecasts, the Company increased its reserves for slow moving inventory by $28.7 million, which is included in cost of sales for the year ended December 31, 2002. In addition, the Company established a reserve of $1.0 million for consignment and demonstration inventory that it has deemed to be obsolete or slow moving, which is included in selling, general and administrative expenses for 2002.

 

The restructuring and impairment charges, inventory reserves and other charges are classified in the accompanying consolidated statements of operations for the year ended December 31, 2002 as follows:

 

(In thousands)

  

Cost of Sales


    

Restructuring and Impairment Charges


      

Selling, General

and Administrative Expenses


  

Total


 

Inventory reserves

  

$

28,686

    

$

—  

 

    

$

—  

  

$

28,686

 

Facility consolidation and severance

  

 

—  

    

 

12,433

 

    

 

—  

  

 

12,433

 

Other non-recurring charges

  

 

—  

    

 

—  

 

    

 

2,533

  

 

2,533

 

Excess 2001 reserve

  

 

—  

    

 

(550

)

    

 

—  

  

 

(550

)

    

    


    

  


    

$

28,686

    

$

11,883

 

    

$

2,533

  

$

43,102

 

    

    


    

  


 

The restructuring and impairment charges, inventory reserves and other charges relate to the following business segments:

 

(In thousands)

    

Advanced Packaging and Automation Systems

  

$

28,967

Industrial and Scientific Technologies

  

 

13,678

Non-segment related

  

 

457

    

    

$

43,102

    

 

2001 Restructuring Plan

 

In 2001, the Company established restructuring reserves for the cost reduction actions implemented at that time, which included restructuring charges of $3.4 million related to workforce reductions, $9.3 million related to facility consolidations and $1.3 million related to other nonrecurring activities. In addition, the Company established additional reserves for excess and obsolete inventory of $24.4 million.

 

F-13


Table of Contents

 

The restructuring and impairment charges, inventory reserves and other charges are classified in the accompanying consolidated statements of operations for the year ended December 31, 2001 as follows:

 

(In thousands)

  

Cost of Sales


    

Restructuring and Impairment Charges


    

Selling, General and Administrative Expenses


  

Discontinued Operations


  

Total


Inventory reserves

  

$

22,717

    

$

—  

    

$

—  

  

$

1,676

  

$